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Background. Satellite cell content in human skeletal muscle has shown to be 
reduced in older versus younger populations.  Further, the ability of older satellite cells to 
proliferate following resistance exercise has been shown to be impaired in older 
individuals; an effect which seemingly limits the hypertrophic response to resistance 
exercise with aging.  Previous in vitro and in vivo research has demonstrated that genes 
involved in satellite cell proliferation, myoblast differentiation, and insulin-like growth 
factor (IGF)-1 signaling are differentially expressed in older versus younger muscle.  
However, no evidence to date exists examining how multiple bouts of resistance training 
affect the genetic and proteomic expression of these indices between younger and older 
age groups.   
Purpose. Therefore, the purposes of this study were to: 1) assess baseline markers 
indicative of satellite cell activity between younger versus older males, 2) examine if 
three sequential bouts of resistance exercise affects markers of satellite cell activity in 
xii 
 
these populations, and 3) examine if the potential age-dependent decrements in satellite 
cell proliferation and/or differentiation were related to decrements in myogenic genes 
and/or a decrement in muscle IGF-1 protein expression in older individuals at baseline 
and throughout the resistance training intervention. 
Methods. Ten younger (age: 18-25 y) and 10 older (age: 60-75 y) males were 
recruited for this study and were instructed to complete 3 lower body workouts (M, W, F) 
consisting of 9 sets of lower-body exercises with 10 repetitions per set at an intensity of 
80% of each individual’s one repetition maximum.  Percutaneous muscle biopsies were 
collected prior to the exercise intervention (T1), 48 hours following workout 1 (T2), 48 
hours following workout 2 (T3), and 24 hours following workout 3 (T4).  A fraction (~20 
mg) of muscle tissue was rinsed of excess blood, connective, and adipose tissue and was 
homogenized in order to assess the concentrations (denoted by [__]) of muscle [DNA], 
[total protein], and [myofibrillar protein].  A second fraction of muscle (~30 mg) was also 
homogenized, total RNA was precipitated out the homogenate and mRNA from the total 
RNA pool was reverse transcribed into cDNA for gene expression analysis.  Finally, a 
third fraction of muscle (~25 mg) was pre-rinsed and homogenized to obtain total protein 
for subsequent Western blotting.  Semi-quantitative real-time reverse transcriptase 
polymerase chain reaction (RT-PCR) was performed to quantitate baseline and changes 
in the mRNA expression levels of CYCLIN D1, cyclin dependent kinase (CDK)4, CDK2, 
P21CIP1, P27KIP1, MYOD, MGF, IGF-IEA, and embryonic myosin heavy chain (MHCEMB) 
with the arithmetic mean of beta-2 microglobulin (B2M) and 28S rRNA (28S) being used 
as an internal control.  Muscle homogenates were also assayed for the protein contents of 
xiii 
 
proliferating cell nuclear antigen (PCNA), hepatic growth factor receptor (c-met), and 
muscle IGF-1.   
Results.  In partial agreement with my initial hypotheses, repeated bouts of 
conventional resistance training increased muscle [c-met], a protein marker indicative of 
satellite cell quantity, in young males 48 hours following the first bout (p < 0.01) and 
decreased this marker in young males 24 hours following the third bout (p < 0.05), 
whereas this value did not change within the old group.  Furthermore, MYOD gene 
expression modestly increased at T2 (p < 0.05) and MHCEMB gene expression modestly 
increased (p < 0.05) at T4 relative to baseline expression values in the younger males.  
Interestingly, MGF expression increased at T2-4 in the older group relative to baseline 
values (p < 0.05), albeit muscle IGF-1 peptide levels remained stable throughout the 
intervention in both age groups.  Other findings from this study indicate that repeated 
training bouts: 1) do not alter the expression of genes indicative of satellite cell activity 
(i.e., CDK2, CDK4, CYCLIN D1, MYOD, P27KIP1, P21CIP1) and/or the expression of IGF-
1EA up to 24-48 hours following exercise in younger or older males, 2) do not increase 
markers of satellite cell proliferation (i.e., muscle [PCNA], and [DNA]) in either age 
group at the sampled time points, and 3) do not alter [myofibrillar protein] or [total 
protein] in either age group at the sampled time points.  In regards to baseline 
physiological parameters, these data illustrate that the CYCLIN D1 gene is expressed 
more highly in older versus younger males (p < 0.05), whereas all other genes and 
markers of satellite cell activity were similar between age groups. 
Conclusions.  The findings from this study suggest: 1) both age groups retain 
proliferative characteristics during resting, unexercised states given the similarities 
xiv 
 
between these groups in regards to muscle [PCNA], muscle [c-met], CDK2, CDK4, as 
well as an increased CYCLIN D1 mRNA expression in older individuals, 2) three 
consecutive bouts of resistance exercise seem to significantly increase a marker 
indicative of satellite cell quantity concomitant with the increased expression of a select 
few myogenic genes in younger participants only (i.e., MYOD at T2 and MHCEMB at T4), 
and 3) repeated exercise bouts facilitated a summation effect on MGF expression only in 
older individuals which is contrary to preliminary research examining this gene in these 
populations.  In summary, these data indicate that more exercise bouts may be needed to 
stimulate satellite cell activity during the initial stages of resistance training in older 
populations which possibly explains why there are impairments in muscle hypertrophy in 
older adults, albeit future research should employ immunohistochemistry in order to 







Sarcopenia (Greek translation meaning “poverty of the flesh”) describes the 
gradual but inevitable decline in muscle mass and strength that accompanies biological 
aging.  Sarcopenia is associated with a sundry of intramuscular events including: 1) a 
reduction in the size and number of fast-twitch (i.e., type II) muscle fibers [1], type II 
motor units [2], and type II fiber satellite cells [3], 2) a reduction of myonuclei in post-
mitotic myofibers [4], and 3) decrements in contractile protein synthesis [5], and 4) 
increases in intramuscular proteolysis [6].  Furthermore, other environmental or 
exogenous cues including: 1) decreases in physical activity [7], 2) inadequate dietary 
protein consumption [8], 3) decrements in endocrinological factors [i.e., bioavailable 
testosterone in males and insulin-like growth factor (IGF)-1 in both sexes [9]], and 4) 
decreases in the production of myogenic autocrine/paracrine factors (i.e., IGF-IEa and 
mechano growth factor (MGF) variants [10]) also accompany and/or exacerbate 
sarcopenia.  While the primary cause of sarcopenia remains elusive, the phenotypic 
manifestation of all of the aforementioned events includes an estimated 20-30% decrease 
in lean body mass between the third and eighth decades of life [11].   
 Resistance exercise can prevent and even reverse the progression of sarcopenia [9, 
12].  Furthermore, resistance exercise has been demonstrated to acutely increase muscle 
protein synthesis and translational efficiency [13], acutely increase markers of satellite 
cell proliferation, and chronically increase satellite cell number [12] and myonuclei 
number per myofiber [14] which is suggestive of myoblast differentiation and fusion 




hypertrophic adaptations following months of structured exercise are limited in older 
versus younger populations [9, 15].  For instance, Petrella et al. [14] have suggested that 
the pre-existing number of satellite cells determines the hypertrophic potential to a 
resistance training regimen.  Likewise, Verdijk et al. [12] have recently discovered that 
the number of satellite cells residing next to type II fibers is limited in older versus 
younger individuals.  Finally, sparse evidence exists suggesting that the proliferative 
capacity of satellite cells [16] as well as the molecular pathways which regulate satellite 
cell activity is dysregulated in older humans [17, 18] and mammals [19].  Taking all of 
this information into consideration, it seems plausible that a dysfunction in satellite cell 
activity with aging exacerbates losses in lean tissue mass. 
The involvement of IGF-1 signaling with satellite cell activity is of particular 
interest due to that fact that: 1) IGF-1 variants [i.e., mechano growth factor (MGF) and 
IGF-1EA] are locally expressed in skeletal muscle following mechanical loading [10, 20], 
and 2) these variants have been shown to possess a causal role in inducing quiescent 
satellite cells to proliferate and differentiate [21].  Interestingly, past literature has 
determined that older rodents and humans exhibit a decrement in MGF and/or IGF-1EA 
mRNA expression following an acute bout of exercise [10, 15, 22], and limited human 
evidence [15, 23] has suggested that the acute post-exercise decrease in MGF/IGF-1EA 
mRNA expression is associated with a long-term decrement in phenotypic adaptations 
(i.e., increases in muscle size) accrued from resistance training.  However, no evidence 
exists in humans demonstrating that the potential age-related decreases in MGF/IGF-1EA 
mRNA and protein expression patterns following a series of resistance exercise bouts are 




1) assess baseline markers indicative of satellite cell proliferation and differentiation 
between younger versus older males, 2) examine if three sequential bouts of resistance 
exercise affects markers of satellite cell proliferation and/or differentiation in both age 
groups, and 3) examine if the potential age-dependent decreases in satellite cell 
proliferation and/or differentiation are related to decrements in muscle MGF/IGF-1EA 
mRNA and IGF-1 protein expression in older individuals.  If there are genes (i.e., MGF, 
IGF-1EA or other cell cycle regulators examined in the current study) that are 
dysregulated between age groups and are linked to decrements in satellite cell activity, 
then the findings from this study will warrant future research in determining the potential 
epigenetic modifications (i.e., genes that are permanently “turned off”) that may occur in 
aging satellite cells and/or post mitotic muscle fibers.  Such findings would heavily 
support the notion of employing gene therapy as a future modality to treat sarcopenic 
populations.  In this regard, transplanting genetically modified satellite cells, which 
possess the transcriptomic pattern of younger satellite cells, into the skeletal muscle bed 
of sarcopenic populations could be employed; this being a method which has already 
been successfully performed with mdx mice [24].  
 
Hypotheses 
1. It is hypothesized that baseline (or pre-exercise intervention) markers indicative 
of satellite cell proliferation (i.e., hepatocyte growth factor receptor (c-met) 
protein, proliferating cell nuclear antigen (PCNA) protein, [DNA], and the mRNA 
expression of CYCLIN D1, cyclin dependent kinase (CDK)4 and CDK2) as well 




protein content, and muscle MGF/IGF-1EA mRNA and IGF-1 protein will be 
greater in younger participants whereas baseline expression of genes indicative of 
terminal differentiation (i.e., MYOD, P21CIP1, P27KIP1) will be greater in older 
participants.   
2. It is hypothesized that three sequential bouts of lower-body resistance exercise 
will continually increase markers of satellite cell proliferation and terminal 
differentiation in both age groups following each exercise bout, albeit increases in 
all of these markers will be diminished in older versus younger males. 
3. It is hypothesized that older participants will express less muscle MGF/IGF-1EA 
mRNA and IGF-1 protein, and the lack of this IGF-1 “signal” will be associated 
with the attenuation in the aforementioned markers of satellite cell activity.  For 
instance, it is likely that there will be negative correlations between the delta 
changes in MGF/IGF-1EA mRNA or IGF-1 protein expression patterns and the 
delta changes in markers of satellite cell activity. 
 
Definitions of Terms and Procedures 
Satellite cells – constitute a majority of muscle precursor cells and reside between the 
sarcolemma of mature muscle fibers and the basement membrane (i.e., connective tissue 
rich in laminin and collagen proteins) 
Quiescence – also referred to as the G0 phase; a state of cellular dormancy prior to 
interphase or mitosis 
Senescence – a state of post mitosis whereby cells can no longer divide 




Proliferation – also referred to as the G1, S, and G2 phases of the cell cycle (which can 
also be termed “interphase”) as well as the M phase; the process of DNA replication and 
subsequent cellular division to increase the number of resident precursor cells 
Differentiation – the process of precursor cells (i.e., satellite cells) ceasing proliferation 
and becoming a more specialized cell type (i.e., a myofiber with a centralized nuclei and 
sparse organellular content compared to mature myofibers); differentiation is signified in 
part by the expression of muscle specific genes including myosin heavy chain isoforms, 
creatine kinase, and other gene species 
Myogenic regulatory factors – are transcription factors (i.e., MyoD, myogenin, MRF4, 
Myf5) that belong to the basic helix-loop-helix protein family; in general these proteins 
form active heterodimers with ubiquitously expressed E proteins which subsequently 
bind to the upstream promoter regions (i.e., E boxes) of genes related to differentiation 
thereby increasing transcription rates 
Myonuclear domain – this is the volume of cytoplasm that is “governed” by a 
myonucleus [reported as 20,000 – 30,000 μm3 [25] across all fiber types]; as a fiber 
grows, more myonuclei must be recruited to conjoin to the cell to maintain cellular 
function [25] 
Kilodalton – abbreviated as kDa; 1 kDa = 1,000 Daltons (Da) where 1 Da is the mass of a 
hydrogen atom; kDa masses are used to describe proteins due to their large molecular 
weights 
C-met – a membrane-bound tyrosine kinase receptor (molecular weights: α-chain = 50 
kDa, β-chain = 145 kDa) whose ligand is hepatocyte growth factor; in skeletal muscle 




Retinoblastoma 1 – This protein (molecular weight: 110 kDa) belongs to the pocket 
protein family and is a nuclear protein that inhibits the progression of the cell cycle [26] 
Cyclins – are proteins that are expressed in a cyclical fashion during the cell cycle 
whereby they bind to and activate cdks; the cyclin of interest in this experiment include 
cyclin D1 (G1 phase cyclin) due to its induction by MGF/IGF-1Ea [27] 
Cyclin dependent kinases – abbreviated as cdks; these enzymes are a group of protein 
kinases that regulate the cell cycle and are active when bound to cyclins [26] 
Cdk-inhibitors – are proteins that inhibit cdks by binding to cdk-cyclin complexes [26]; 
the cdk-inhibitors of interest in this investigation include p21Cip1 and p27Kip1 due to the 
fact that they are obligatory for satellite cell cycle exit and differentiation [28], they are 
exercise inducible [29], and they are differentially expressed between age groups [19, 30] 
Myofibrillar protein – is protein that makes up myofibrils; for example, some of these 
proteins include the various isoforms of myosin, actin, troponin, titin, and nebulin 
Total muscle protein – includes all membrane-associated proteins (i.e., receptors and 
cytoskeletal proteins), cytoplasmic proteins (i.e., metabolic enzymes, nuclear receptors, 
etc), myofibrillar proteins, and nuclear proteins (i.e., transcription factors) 
Embryonic myosin heavy chain – abbreviated as MHCemb; this myosin isoform has been 
shown to be expressed in very small regenerating fibers and is thought to signify the 
presence of newly differentiated myotubes that fuse to pre-existing muscle fibers [31] 
DNA – deoxyribonucleic acid is a double-stranded molecule that makes up 
chromatin/chromosomes which contain genetic information that is able to be transcribed 




Total RNA – ribonucleic acid are single-stranded molecules that include three subtypes: 
1) ribosomal RNA (or rRNA including the 18S, 5.8S, 28S and 5S subtypes) make up 
~80% of the total RNA pool which are thousand nucleotide length  molecules and, along 
with ribosomal proteins, make up the 80S ribosome which carries out protein synthesis; 
2) transfer RNA (or tRNA) make up ~15% of the total RNA pool and are 70-90 
nucleotide length RNA molecules that transfer amino acids to growing polypeptide 
chains during protein synthesis; 3) messenger RNA (or mRNA) make up ~5% of the total 
RNA pool which are hundred nucleotide length molecules that carry genetic information 
from genes to ribosomes 
Translational efficiency – the rate of mRNA translation into proteins; if translational 
efficiency increases then rates of translation are enhanced without increases in the 
number of 80S ribosomes; an effect which is primarily due to an increase in translation 
initiation [32] 
Translational capacity – The number of ribosomes which are available to translate mRNA 
transcripts; translational capacity increases in cells after growth factor stimulation via the 
phosphorylation of ribosomal protein S6 and the subsequent preferential translation of 
ribosomal protein mRNAs; after new ribosomes are formed (i.e., translational capacity 
increases) then other mRNAs (i.e., cell cycle regulator mRNAs) are preferentially 
translated [33] 
Muscle homogenation – refers to the process of using various buffers to solubilize muscle 
into a solution for subsequent substrate analyses 
Cell lysis buffer – a muscle homogenation buffer that yields total muscle protein 




Tri reagent – a solution that contains chemicals (i.e., phenol and guanidine thiocyanate) 
to catalyze an immediate inhibition of RNase activity; samples are: 1) first homogenized 
or lysed in Tri Reagent and the homogenate is separated into aqueous and organic phases 
by chloroform addition and centrifugation, 2) RNA in the upper aqueous phase is then 
precipitated by the addition of isopropanol, washed with ethanol and solubilized with 
RNase-free water for subsequent gene expression analysis 
Western blotting – a multi-step process whereby proteins from muscle homogenates are:  
1) separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis, 2) transferred 
to a nitrocellulose membrane, and 3) probed using a primary antibody specific to a 
protein of interest, a secondary antibody conjugated to an enzyme which is specific to the 
primary antibody, and a substrate which luminesces when exposed to the secondary 
antibody-enzyme conjugate  
Ponceau S staining – this procedure is used to mathematically correct Western blotting 
values for lane-to-lane loading variations 
Real time reverse transcriptase polymerase chain reaction – a multi-step procedure which 
uses gene-specific primer sequences and a fluorescent tracer to detect the expression of 
explicit mRNA transcripts (termed genes of interests or GOIs) 
Housekeeping gene – a gene that is used to normalize GOI expression in order to correct 
for well-to-well loading variations between samples 
Melt Curve – a post hoc procedure used to confirm the presence of one cDNA 
amplification product (or gene) during PCR; if multiple peaks are present in a given well 
following melt curve analysis then this signifies the presence of other gene products (i.e., 




Hoechst staining – is a method discriminatingly detects double-stranded nucleotides (i.e., 
DNA) in the presence of RNA and other nucleotides by the binding of Hoechst dye to 
AT-rich sequences in the minor groove of DNA; this method can be performed on crude 
muscle homogenates (i.e., no multi-step phase separation of DNA is required) to 
determine if DNA replication has occurred [22] 
One repetition maximum – the maximum amount of weight a participant is able to 
eccentrically and concentrically perform on a given exercise apparatus 
 
Abbreviations 
Cdk – cyclin-dependent kinase 
p21Cip1 – cyclin-dependent kinase inhibitor 1A  
p27Kip1 – cyclin-dependent kinase inhibitor 1B 
pRb – retinoblastoma 1 
PCNA – proliferating cell nuclear antigen  
MyoD – myogenic differentiation 
MHCemb – embryonic myosin heavy chain 
RNA – ribonucleic acid 
DNA – deoxyribonucleic acid 
IGF – insulin-like growth factor 
MGF – mechano growth factor 
HGF – hepatocyte growth factor 
MRF – myogenic regulatory factor 
RT-PCR – reverse transcriptase polymerase chain reaction  




GOI – gene of interest 




Ten older (60-75 y) and ten younger (18-25 y) males who were not currently 
participating in any form of resistance training with their lower bodies were recruited for 
this study.  Prior to data collection, all participants completed a written statement of 
informed consent and medical history questionnaire. Eligibility inclusion criteria included 
the following: 1) apparently healthy participants that did not participate in a structured 
lower-body resistance exercise regimen consistently (i.e., at least one time per week) one 
year prior to participation in this study, 2) participants were told to refrain from smoking, 
alcohol, tobacco or caffeine for the duration of the study, 3) participants could not have 
consumed ergogenic nutritional supplements for at least 3 months prior to the start of the 
study, 4) participants could not be affected with metabolic disorders including heart 
disease, arrhythmias, diabetes, thyroid disease, or hypogonadism, 5)  participants could 
not have a history of pulmonary disease, hypertension, hepatorenal disease, clotting 
disorders, musculoskeletal disorders, neuromuscular/neurological diseases, autoimmune 
disease, cancer, peptic ulcers, or anemia, 6) participants could not have any orthopedic 
problems (e.g., previous surgery, joint replacements, etc.) or previously diagnosed 
neuromuscular disease that prevented them from participating in the resistance training 
sessions, 7) participants could not be taking prescription medications indicated for heart, 
pulmonary, anti-coagulant, anti-hypertensive, psychotropic, neuromuscular/neurological, 




contraindication for exercise testing as outlined by the American College of Sports 
Medicine (provided below): 
Absolute Contraindications to Exercise Testing 
– A recent significant change in the resting ECG suggesting significant ischemia, recent 
MI or other acute cardiac event 
– Unstable angina 
– Uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise 
– Symptomatic severe aortic stenosis 
– Uncontrolled symptomatic heart failure 
– Acute pulmonary embolus or pulmonary infarction 
– Acute myocarditis or pericarditis 
– Suspected or known dissecting aneurysm 
– Acute systemic infection, accompanied by fever, body aches, or swollen lymph glands 
Relative Contraindications to Exercise Testing 
– Left main coronary stenosis 
– Moderate stenotic valvular heart disease 
– Electrolyte abnormalities (e.g. hypokalemia, hypomagnesemia) 
– Severe arterial hypertension (i.e. SBP>200 and/or DBP >110) at rest 
– Tachydysrhythmia or bradydysrhythmia 
– Hypertrophic cardiomyopathy and other forms of outflow tract obstruction 
– Neuromuscular, musculoskeletal, or rheumatoid disorders that are exacerbated by 
exercise 




– Ventricular aneurysm 
– Uncontrolled metabolic disease (e.g., diabetes, thyrotoxicosis, or myxedema) 
– Chronic infectious disease (e.g., mononucleosis, hepatitis, or AIDS) 
– Mental or physical impairment leading to inability to exercise adequately 
 
Eligibility inclusion criteria list continued: 9) Participants could not have an allergy to 
Lidocaine, 10) Participants could not have an allergy to latex, or 11) Older participants 
that did not provide written medical clearance from their primary physician. 
 
Assumptions 
1. Participants filled out medical history questionnaires correctly. 
2. Participants followed the guidelines established by the investigators throughout the 
duration of the study (i.e., participants refrained from consuming supplements, 
tobacco, etc; participants did not exercise between testing sessions; participants 
reported to the laboratory prior to each session at least 12 hours fasted).  
3. The exercise stimulus employed during the three sequential exercise bouts was an 
adequate stimulus to elicit favorable physiological responses. 




Theoretical limitations  
1. Younger and older participants were recruited from the University of Oklahoma 




Exercise Science.  Furthermore, participants received a $150 incentive for their time 
and effort throughout the duration of the study.  These two facets theoretically violate 
the idea of random subject selection. 
Methodological limitations 
1. Muscle [DNA] determination: using Hoechst staining, delicate increases in DNA 
caused by increases in DNA synthesis from satellite cell activation and myoblast 
proliferation will be able to be detected.  This method has been successfully 
employed by Haddad and Adams [22] to determine the age-related differences in 
DNA content within the skeletal muscle of rats.  The predominant limitation to this 
method, as proposed by Booth [34], includes quantifying DNA from other cells in the 
muscle bed including stromal vascular cell lines (i.e., fibroblasts, smooth muscle, 
epithelial cells) infiltrating leukocytes, intramuscular adipocytes as well as DNA from 
pre-existing muscle fibers.  To minimize this interference, muscle samples will be 
blotted dry on sterile absorbent tissue and dissecting tools were used to cleanse each 
sample of excess adipose tissue and connective tissue.  Furthermore, muscle 
homogenates from each sample were immunoprobed for a marker (CD163) 
exclusively expressed by monocytes/macrophages that potentially enters the muscle 
tissue following each exercise bout. 
2. Interpreting changes in [myofibrillar protein]: the addition of myofibrils can arise 
from: 1) satellite cell differentiation and fusion to pre-existing myofibers and/or, 2) an 
increase in myofibrillar protein synthesis in pre-existing muscle fibers.  Thus, 
[myofibrillar protein] was expressed as raw data and was corrected for [DNA] in 




protein]: [DNA] increased then this signified an increase in myofibrillar protein 
synthesis in the absence of satellite cell proliferation/differentiation/fusion.  
Conversely, if [myofibrillar protein] and [DNA] increased, but the [myofibrillar 
protein]: [DNA] remained statistically unaltered then this (along with concomitant 
increases in MRF, cdk-inhibitor, and MHCEMB mRNA expression patterns) strongly 
suggested that satellite cell proliferation/differentiation/fusion to pre-existing fibers 







REVIEW OF LITERATURE 
 
The Findings of Alexander Mauro (1961): a Historical Perspective 
Satellite cells are mononuclear muscle precursor cells that lie between the 
sarcolemma of mature muscle fibers and the basal lamina, or connective tissue in the 
extracellular matrix.  These “resident stem cells” have been under intense investigation 
since their discovery in frog muscle by Alexander Mauro [35].  Furthermore, Mauro’s 
findings have led to heated debates as to whether satellite cells are even needed for 
exercise-induced muscle hypertrophy to occur.  In this regard, a wealth of evidence has 
demonstrated that chronic mechanical loading in rodents and humans induces an increase 
in satellite cell number and an eventual increase in post-mitotic fiber nuclei; a 
phenomenon which is thought to occur as a result of the fusion of differentiated, 
mononucleated satellite cells to pre-existing fibers [36].  Likewise, inducing the necrosis 
of satellite cells with radiation prior to exercise training has been shown to completely 
abolish muscle growth in rodents further demonstrating their integral role in exercise-
induced hypertrophy [37].  However, a select group of scientists (in particular Drs. Esser 
and McCarthy) have provided a unique perspective (supported by sparse evidence) that 
satellite cells assume a passive role in skeletal muscle physiology and that muscle growth 
is chiefly due to an increase in the post-mitotic myonuclear expression and translation of 
myofibrillar proteins followed by their subsequent incorporation into pre-existing 
myofibrils [38].  When integrating these two perspectives, it seems plausible that the 
acute-phase hypertrophic response to resistance exercise involves the post-mitotic 




subsequent incorporation into pre-existing myofibrils, whereas the chronic hypertrophic 
response to a series of exercise stimuli is mediated by the addition (fusion) of 
differentiated satellite cells to pre-existing muscle fibers [39]. 
Upon his discoveries, Mauro devised three hypotheses as to how satellite cells are 
fabricated.  First (Figure 1A), Mauro speculated that the myonuclei of a damaged muscle 
fiber “gathers up” cytoplasm from the damaged multinucleated cell in order to spawn a 
new, undamaged satellite cell that is able to regenerate a new muscle cell.  This 
hypothesis was, however, deemed “an unusual mechanism for vertebrate systems” by 
Mauro given that sparse evidence supported this model.  The second hypothesis coined 
by Mauro (Figure 1B) was that satellite cells were “remnants of embryonic development” 
that remained in the muscle bed following the fusion of mononucleated myoblasts and 
subsequent formation of multinucleated myotubes.  Mauro goes on to say that these 
remaining reservoirs of unincorporated satellite cells “…are ready to recapitulate the 
embryonic development of skeletal muscle fiber when the main multinucleate cell is 
damaged.”  Finally, Mauro’s third hypothesis (Figure 1C) was that satellite cells were 
“wandering cells” that infiltrate the muscle bed and await the proper conditions to be 
activated. 
The recent advent of more discriminatory microscopic techniques allowed 
scientists to confirm that Mauro’s second hypothesis (Figure 1B) was the most apparent 
explanation of the origin of satellite cells.  For example, Schienda et al. [40] used reporter 
protein methods (i.e., infecting chick somites with a retrovirus fused the green fluorescent 
protein reporter) to label and routinely examine the morphogenesis of mammalian 




short, these authors concluded that somitic cells, which are embryonic cells lateral to the 
embryonic neural tube that eventually give rise to skeletal muscle, are also the origin of 
satellite cells.  It is interesting to note, however, that Mauro’s third hypothesis (Figure 
1C) may also occur due to the presence of heterogeneously phenotypic satellite cells.  For 
instance, Rantanen et al. [41] discovered that a subpopulation of satellite cells exist in the 
muscle bed which are able to express myogenin and commit to differentiation without 
proliferation within 4-8 hours of muscle damage, whereas another population of “stem 
satellite cells” also exist and do not divide until 24 hours following muscle damage.  To 
summarize their findings, these authors stated:  
“…we propose that there are two populations of precursor cells: committed 
satellite cells, which are ready for immediate differentiation without preceding 
cell division, and stem satellite cells, which undergo mitosis before providing one 
daughter cell for differentiation and another for future proliferation.” 
In an attempt to explain this phenotypical divergence, Zammit et al. [42] authored an 
extensive review that provides a wealth of evidence to suggest other multipotent stem 
cells including interstitial cells, endothelial-associated cells, and side population cells 
(i.e., bone marrow-derived hematopoietic stem cells) share similar molecular signatures 
(or express several of the same proteins) and are able to adopt the myogenic lineage 
following transplantation experiments.  Regardless, Zammit and colleagues also admit 
that scientists have been relatively unsuccessful in determining whether or not 
“wandering stem cells” meaningfully contribute to the satellite cell reservoir.  Further, 
these authors conclude that the heterogeneous phenotypic activity of satellite cells may be 





Overview of the Cell Cycle 
According to historical literature, the eukaryotic cell cycle has been a subject of 
intense interest for physiologists since the microscopic examination of the nematode 
(Trichinella spiralis) life cycle by German scientist Rudolf Virchow in the 1850’s [43].  
The cell cycle is comprised of several distinct phases which have been extensively 
reviewed [44-48] and will be briefly described in this section.  During the first phase (G1, 
or Gap 1) the cell body grows and there is a concomitant increase in the production of 
enzymes that are required for DNA replication.  Once the cell has attained a certain size it 
enters the S (synthesis) phase, whereby the cell duplicates each chromosome.  The cell 
then enters the G2 (Gap 2) phase whereby a significant amount of protein synthesis 
occurs; mainly involving the production of microtubules which make up mitotic spindles 
that are obligatory for mitosis.  Finally, duplicated chromosomes are separated during the 
M (mitosis) phase and the cell subsequently divides (i.e., cytokinesis) spawning the 
formation of two genetically identical daughter cells.  After mitosis is complete, the two 
daughter cells can continue to replicate (i.e., re-enter the G1 phase), or they can exit from 
the cell cycle and enter a mitotically quiescent stage (G0) until it is again activated by a 
mitogenic stimulus.  In most mammalian cells, the entire cell cycle has been observed to 
last between 10 and 30 hours [48]. 
While mechanisms of the cell cycle remained speculative during the subsequent 
decades following Virchow’s nematode studies, the endeavors of geneticists Drs. Leland 
Hartwell, Paul Nurse, and Timothy Hunt during the 1970’s and 1980’s revealed explicit 
genes, which were later termed “cyclin dependent kinases” at the Cold Harbor 




[26].  Cdk proteins possess serine/threonine kinase domain, although scientists 
determined that these enzymes must to bind to cyclin proteins subsequently be 
phosphorylated by a cdk-activating kinase in order to exert their biochemical effects [26].  
Furthermore, specific active cdk-cyclin complexes are typically localized or sequestered 
into the nucleus during different phases of the cell cycle where they act to phosphorylate 
downstream targets.  For instance, immunofluorescence microscopy has been used to 
localize cyclin A in the nuclei of proliferating cells during and following the S phase, 
whereas cyclin B1 accumulates in these cells during the G1, S and G2 phases and is 
translocated into the nucleus during the M phase when it is predominantly active [49].  
The functional ramifications of cdk-cyclin nuclear localization are evident given that the 
nuclear localization of cyclin A during the S phase (discussed in the sentence above) 
parallels observations to suggest that cdk2-cyclin A phosphorylates nuclear proteins 
involved in DNA replication, DNA repair, and histone modification [26].   
It is noteworthy to mention that bioinformatic analysis has been used to identify 
29 mammalian cyclins which possess a conserved cyclin box domain that act as binding 
templates for cdks [26].  Likewise, 20 cdk proteins have been identified which possess a 
conserved serine/threonine kinase domain.  However, cdks and cyclins of particular 
interest (i.e., those firmly linked to different phases of the cell cycle as well as those that 
are affected with exercise and aging in human skeletal muscle) will be discussed in 
subsequent paragraphs. 
 
Satellite Cell Physiology and Molecular Markers of Satellite Cell Activation, 




As mentioned previously, satellite cells are mononuclear muscle precursor cells 
that reside between the sarcolemma of mature muscle fibers and the basal lamina of the 
extracellular matrix.  A prominent molecular feature of satellite cells includes the co-
expression of the paired box (PAX)3/7 transcripts which encode transcription factors that: 
1) commit these cells to the myogenic lineage [50], and 2) act in concert with other 
stimuli mentioned in subsequent paragraphs to induce the expression of MRFs during 
myogenesis [51].  Under normal physiological conditions, satellite cells remain in a non-
proliferative, quiescent state (i.e., G0).  However, resident satellite cells can undergo 
sequential activation, proliferation, differentiation, and fusion events when skeletal 
muscle is exposed to trauma (i.e., experimental crushing or exposure to myotoxins), 
mechanical stress (i.e., overloading through synergist ablation or excessive stretching), or 
an adequate exercise stimulus [36].  The following paragraphs will describe these 
phenomena in greater detail as well as molecular markers that simultaneously appear 
during these events. 
Divergent satellite cell populations.  As mentioned previously, some researchers 
suggest that two distinct populations of satellite cells exist which display different 
phenotypic proliferative characteristics (depicted in Figure 2).  In support of this 
hypothesis, Ambrioso et al. [36] suggest that rapidly (i.e., 4-8 hours) proliferating and 
differentiating satellite cells: 1) readily replicate thereby replenishing the satellite cells 
pool, and 2) are able to differentiate and fuse to pre-existing fibers in order to increase the 
number of myonuclei and maintain an ordinate myonuclear domain.  Conversely, the 
prolonged (i.e., > 24 hours) self-renewing stem cells residing in muscle tissue, which may 




stem cells, 2) are capable of differentiating without expressing markers of differentiation 
(i.e., MRFs), and 3) have the ability to differentiate into vascular or neural lineages 
following injury or extensive muscle tissue remodeling events.  Interestingly, Booth’s 
group [52] demonstrated that primary muscle progenitor cell populations isolated and 
cultured from rat skeletal muscle contain approximately 90% of “conventional” satellite 
cells (i.e., Pax7+, desmin+, MyoD+) whereas 10% of the isolated cells expressed 
hematopoietic stem cell markers (i.e., CD34+, CD45+) prior to passaging.  Therefore, 
this evidence suggests that the addition of myonuclei to post-mitotic fibers plausibly 
occurs through the accretion of conventional satellite cells as well as satellite stem cells 
which possess different phenotypic characteristics. 
Satellite cell activation. The binding of growth factors including IGF-1, 
hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF), nerve growth 
factor, leukemia inhibitory factor (LIF), and platelet-derived growth factor (PDGF) to 
cognate receptors present on the sarcolemma of satellite cells has been postulated to 
initiate satellite cell activation [36].  Once satellite cell activation occurs, a quiescent 
satellite cell enters the cell cycle (at this point, the cell is termed a proliferating myoblast) 
which is a multi-step process that yields two genetically identical daughter myoblasts 
from a single parent satellite cell.  Quiescent satellite cells are morphologically flat, 
spindle-shaped cells with little cytoplasmic volume whereas myoblasts exhibit increases 
in cytoplasmic volume and organellular content [i.e., mitochondria, rough endoplasmic 
reticulum, and total RNA content which are needed for ATP production and protein 
synthesis during satellite cell growth and proliferation, respectively [53]].  Molecular 




with the c-met receptor as well as the expression of c-fos and c-jun which are deemed 
“early response genes” that act as transcription factors to increase the sequential 
expression of other genes needed for cellular proliferation.  Other cell-specific markers 
that are used to microscopically quantitate satellite cell number include c-met, neural cell 
adhesion molecule (NCAM), and PCNA protein expression [15]. 
Interestingly, recent evidence suggests that physical activity transiently (i.e., 0-24 
hours post-exercise) increases the myogenic (or muscle-borne) expression of a muscle-
specific IGF-1variant [10, 20] and LIF [54] as well as the circulating appearance and 
possible extracellular liberation of HGF that is localized in muscle tissue in an inactive 
pro-peptide form [55].  Of particular relevance are the numerous investigations that have 
demonstrated that the myogenic expression of IGF-1 mRNA splice variants [i.e., liver-
specific/systemic IGF-IEa and MGF] occurs in response to resistance exercise [10, 56, 
57], eccentric contractions [58, 59], or functional overloading protocols in rodents [60].  
Furthermore, recent evidence suggests that the transient myogenic expression of MGF 
following exercise acts to induce satellite cell activation and proliferation, whereas the 
prolonged myogenic expression of IGF-IEa following exercise (i.e., > 48 hours) acts to 
initiate myoblast differentiation [21].  Hence, the aforementioned literature suggests that 
exercise stimuli increase the expression and/or release of local growth factors (of interest 
IGF-1 variants) in post mitotic fibers which, in turn, act to initiate satellite cell activation 
(via MGF signaling), myoblast proliferation (via MGF signaling), and likely the 
differentiation myoblasts into myocytes (via IGF-IEa signaling) that are capable of fusing 




It is noteworthy to contemplate whether or not sarcolemmal and/or myofibrillar 
protein disruption, which commonly accompanies high-intensity eccentric muscle 
contractions, is obligatory for the subsequent occurrence of satellite cell activation [36].  
In this regard, low-frequency, non-damaging electrical stimulation protocols in rodents 
[61] as well as chronic, low-intensity cycle ergometry training in humans [62] is capable 
of significantly increasing satellite cell activation and proliferation.  Further, Mackey et 
al. [63] demonstrated that performing 3 weekly bouts of low intensity (15% 1RM) versus 
high intensity (70% 1RM) leg extensions induced a significantly greater increase in the 
number of active satellite cells in the former training group after 12 weeks of training; 
this being a peculiar finding due to the fact that greater weightlifting intensities, even 
when standardized for training volume, have been shown to elicit more pronounced 
skeletal muscle damage [64].  Interestingly, Bamman et al. [59] also reported that 
concentric versus eccentric squats elicited similar increases in myogenic IGF-1 mRNA 
expression patterns 48 hours post-exercise (transcript variants were not discriminated) 
even though the eccentric training session elicited a more substantial increase in serum 
markers of myofiber damage.  Finally, recent evidence exists demonstrating that a single, 
high volume/high intensity bout of eccentric leg extensions (i.e., a protocol that was 
meant to elicit myofibrillar disruption) substantially increased satellite cell proliferation 
in the absence of sarcolemma and/or myofibrillar protein disruption [65].  In 
summarizing their findings these authors stated, 
“Despite 210 maximum voluntary contractions that were eccentric in nature 
being performed by the subjects in this study, seven of the eight subjects did not 




desmin or dystrophin proteins was found in the cellular membrane of the 
myofibres and, to support this, the fibronectin protein was not found within the 
myofibres. This indicated that the sarcolemma was undamaged.  Even with the 
lack of myofibre necrosis, an increase in the number of satellite cells was 
confirmed by positive staining for NCAM, an abundant protein observed on the 
surface of early embryonic myotubes.” 
Therefore, while past research has demonstrated that satellite cell activity and myofiber 
damage synchronously increases following exercise, the aforementioned findings 
cumulatively suggest that myofibrillar damage accompanying eccentric muscle actions 
does not seem to be obligatory for satellite cell activation.  Conversely, the resistance or 
endurance exercise-induced expression of IGF-1 variants from mature myofibers, note 
that evidence exists demonstrating that endurance training is also able to increase 
myogenic IGF-1 expression [66], as well as increases in the myonuclear domain 
following a series of exercise bouts (this mechanism being discussed in a subsequent 
paragraph) appear to be a candidate mechanisms that facilitate increases in satellite cell 
activity. 
Satellite cell proliferation. The molecular signature of myoblast proliferation will 
be described in regards to each of the following phases of the cell cycle:  
1) G1 phase: this phase is marked by the transient expression of G1 phase cyclins 
(cyclins D and E) and cdks (cdk4, cdk6, and cdk2) in satellite cells which act in tandem 
as catalytic cyclin-cdk heterodimers to hyperphosphorylate the retinoblastoma protein 
(pRb) in the satellite cell nucleus and facilitate DNA synthesis.  Of particular importance, 




pRb during the early portion of the G1 phase, whereas cdk2-cyclin E continue an 
irreversible pRb phosphorylation process in the latter half of the G1 phase [26].  It should 
be noted that hypophosphorylated pRb binds to and inhibits the activity of activator E2F 
transcription factors (E2F1, E2F2, and E2F3a) while recruiting histone deacetylases to 
chromatin which increases chromatin packing; these effects being deleterious to the 
transcription of genes necessary for DNA synthesis [67].  It should be noted that some 
but not all of the DNA synthesis genes whose expression is increased by activator E2F 
transcription factors include DNA polymerases α/δ (needed for leading and lagging 
strand synthesis) and thymidine kinase (needed for thymine nucleotide synthesis) [67].  It 
is also noteworthy that, at this point of the cell cycle, the expression and activity of MRFs 
(of interest myogenin and MyoD which initiate the differentiation process in proliferating 
myoblasts) have been reported to be lower than baseline levels if myoblasts continue 
proliferating or exit into quiescence following proliferation [27].  Conversely, MyoD 
expression can transiently peak and fall (via Ser200 phosphorylation and subsequent 
ubiquitin-mediated degradation) during the G1 phase and peak again during the late G2 
phase in the subgroup of myoblasts that are induced to differentiate following the cell 
cycle; an effect which likely begins the differentiation process while proliferation is 
concomitantly occurring [68].  To summarize, an increased expression of G1 phase 
cyclins and a decreased expression of MRFs are surrogate markers indicative of myoblast 
proliferation. 
2) S phase: DNA synthesis, or the replication of all of the genetic material (i.e., 
chromatin) in a mitotically activated satellite cell to yield two copies of genetically 




molecular signatures of the S phase include: 1) the continued maintenance of pRb 
hyperphosphorylation, 2) the appearance of PCNA proteins at the focal points of DNA 
replication which act as co-activators of DNA polymerase δ [69], and 3) the increased 
expression and enzymatic activity of the cdk2-cyclin A heterodimer which acts to cease 
DNA replication towards the end of the S phase by phosphorylating and inactivating 
proteins such as E2F1 [70]. 
3) G2 and M phases: As mentioned previously, the synthesis of proteins needed 
for chromosomal segregation during mitosis (i.e., microtubules and microtubule-
associated motor proteins) occurs in the G2 phase [44].  Further, the completion of DNA 
synthesis and repair are completed prior to the termination of the G2 phase [44].  A 
prominent molecular marker which signify that cells are existent in the G2 phase includes 
the increased expression and enzymatic activity of the cdk1-cyclin A/B complexes which, 
as evidenced through knock-out and mutational knock-in cdk1 studies, are obligatory for 
entry into mitosis [71].  Another manner to detect the G2 and M phases includes using 
proliferating cell culture models to detect DNA content with a fluorescent dye or BrdU 
labeling, and allocating fluorescent-activated cell sorting (FACS) analysis with 
bioinformatic software modeling to determine which portion of the cells exist in these 
two phases.  While these methodologies have recently been performed in myoblasts that 
were treated with pharmaceutical agents [72], using FACS-based methods are relatively 
cost-inefficient and require extraneous amounts of tissue for analyses. 
Satellite cell differentiation.  Differentiation describes the process of a precursor 
cell becoming a more specialized cell type.  For instance, a proliferating myoblast is a 




containing specialized organelles including myofibrils with contractile elements, 
mitochondria, sarcoplasmic reticulum, and enzymes that are integral for fuel metabolism.  
If a myoblast does not differentiate following proliferation then it will not possess the 
functional characteristics of a mature myofiber; this occurrence being due to the fact that 
undifferentiated myoblasts are obliged to genomically enter differentiation prior to 
expressing genes that encode the aforementioned functional, muscle-specific proteins. 
Physiological cues that induce myoblast differentiation remain relatively obscure 
compared to the below-mentioned markers of differentiation.  In cell culture experiments, 
removing mitogenic proliferation media (i.e., chick embryo extract- or fetal calf serum-
containing medium) and replacing it with DMEM (i.e., a differentiation medium 
containing amino acids, salts, glucose and vitamins supplemented with insulin as a 
surrogate growth factor) induces myoblast differentiation [73].  Interpolating these 
findings to a physiological context suggests that the immediate post-exercise increase in 
serum and/or muscle-derived growth factors (i.e., MGF, HGF, LIF, etc) acts to induce 
satellite cell activation and proliferation whereas their eventual disappearance from the 
muscular milieu may induce a subset of myoblasts to differentiate.  Conversely, recent 
evidence suggests that a delayed (i.e., > 48 hours post-exercise) expression of the IGF-
IEa splice variant may act to induce a subset of proliferating myoblasts to differentiate 
making this gene and its encoded protein extremely relevant markers of interest [21].  In 
partial support of this hypothesis, Masuro and Rosenthal [74] transfected rat myoblasts 
with an IGF-1 gene that was under control of the myosin light chain promoter.  Using 
these methodologies, the IGF-1 gene could only be expressed once myoblasts exist in a 




to be expressed.  These authors reported that, compared to non-transfected myoblasts, the 
post-mitotic expression of IGF-1 induced the expression of myogenin, creatine kinase, 
and MHCemb; all of these genes being markers of differentiation.  Likewise, there is 
similar mammalian cell culture evidence to suggest that the stimulating the IGF-1 
signaling pathway is capable of inducing differentiation [75].  Thus, there is ample 
evidence to suggest that IGF-1 splice variants can differentially act to increase satellite 
cell activation, proliferation, and differentiation.  Exactly how IGF-IEa signaling 
mechanistically differs from MGF signaling, however, remains obscure given that both 
peptides plausibly act through IGF-1 receptor signaling cascades [i.e., MAPK, Akt-
mTOR activation, and non-PI-3kinase mechanisms [74]], albeit MGF also appears to 
induce satellite cell proliferation through an unidentified IGF-1 receptor-dependent 
pathway [76].   
Finally, it has been postulated that the size of myonuclear domains cues myoblast 
differentiation (depicted in Figure 2).  In support of this hypothesis, Petrella et al. [15] 
state, 
“…a ceiling size on the [myonuclear] domain has been suggested based upon the 
concept that sufficient expansion of the myonuclear domain likely puts each 
nucleus under greater strain to supply the necessary gene products, driving a 
demand for the addition of new myonuclei to make possible continued growth 
beyond the domain ceiling.” 
Further, these authors have demonstrated that favorable respondents to chronic resistance 
exercise, or those that exhibited the largest increases in muscle fiber cross-sectional area 




exhibited the largest increases in myonuclear addition (+25% in myonuclear number, p < 
0.05) [15].  It is noteworthy to mention that modest responders (+20% CSA, p < 0.05) 
and non-responders to resistance exercise (no change in CSA, p > 0.05) in this same 
study exhibited a modest increase (+8% in myonuclear number, p < 0.05) and no change 
in myonuclear number, respectively.  In attempting to explain these phenomena, the 
authors inexplicitly stated, “Expansion of the myonuclear domain may drive myonuclear 
addition [i.e., differentiation and fusion of myoblasts] by placing strain on existing nuclei 
to produce adequate gene products for the growing myofiber.”  However, these authors 
have similarly reported that the prevalence of serum/muscle myostatin protein levels 
and/or the myogenic mRNA expression of IGF-1EA, MGF, MYOD, MYOGENIN, 
CYCLIN D1, MYOSTATIN, P27KIP1, P21CIP1, and/or ACTIVIN IIB (a component of the 
myostatin receptor) determine the degree of myofiber hypertrophy, myonuclear number 
increases, and/or satellite cell activity following prolonged training [14].  Therefore, the 
identification of an explicit signal(s) originating from post-mitotic nuclei that cues 
myoblast differentiation/fusion once the myonuclear domain ceiling is breached remains 
to be determined. 
Prominent molecular markers of differentiation include the increased expression 
and activity of MRFs (of interest MyoD and myogenin), cdk inhibitors (of interest  
p21Cip1 and p27Kip1), and pRb [68].  Conversely, there is a decrement in the expression of 
transcription factors termed inhibitors of DNA binding (i.e., the Id1, Id2, and Id3 
isoforms) which bind to and inhibits MRF DNA binding affinity to upstream 
promoter/enhancer regions; events which abolish MRF-induced increases in muscle-




p21Cip1 facilitate differentiation by virtue of binding to and inhibiting the activity of all 
cdk-cyclin complexes [78].  Likewise, an increase in pRb expression halts the cell cycle 
by re-sequestering E2F transcription factors which act to induce the expression of 
proteins needed for DNA synthesis as previously mentioned.  Finally, the increased 
expression and activities of MyoD (during proliferation) and myogenin (estimated to 
occur 12 hours following the onset of differentiation) occur in proliferating myoblasts 
that are cued to exit the cell cycle and differentiate [53, 77].  Other molecular  markers 
that indicate early differentiation events include the expression of muscle-specific genes 
and proteins including creatine kinase [53], desmin [79], alpha-actinin [79], alpha-actin 
[79], titin [79], troponin-I [79], and MHCemb [31] followed by the expression of adult 
myosin isoforms [53].  Furthermore, the appearance of organized myofibrils has been 
reported to occur 15-24 hours following mitosis in proliferating myoblasts that were 
induced to differentiate [79].  Taking all of the aforementioned findings into 
consideration (i.e., summating the time needed for proliferation and differentiation to 
occur) suggests that the de novo formation of a differentiated myocyte occurs at least 48 
hours following a mitogenic stimulus such as resistance training. 
Finally, it is obligatory to describe the multifaceted mechanisms of MRFs due to 
their purported roles in cuing myoblast differentiation.  As mentioned previously, the four 
MRFs include MyoD, myogenin, Myf5, and MRF4.   In short, MRFs are classified as 
basic helix-loop-helix (bHLH) proteins that bind to ubiquitously expressed E proteins to 
form transcription factor heterodimers.  Once these active heterodimers are formed, they 
bind to E-box sequences that are present in upstream promoter/enhancer DNA sequences 




examples) as well as chromatin remodeling enzymes (i.e., SWI-SNF and histone acetyl 
transferases) to affect the expression of various genes [80].  As alluded to previously, 
there is a distinct temporal expression of the MRFs during the differentiation process 
with MyoD and Myf5 being expressed first followed by myogenin and MRF4 [42].  
However, transgenic (i.e., ectopic expression) cell culture experiments have indicated that 
introducing genes that encode each of these MRFs into precursor muscle cells induces 
differentiation [81]; a phenomenon which suggests that MRFs possess functional 
redundancy.  Likewise, a series of knockout experiments have led scientists to believe 
that Myf5 is functionally redundant to MyoD and MRF4 is functionally redundant to 
myogenin [42].  Therefore, it seems as if the expression of MyoD and myogenin are 
obligatory for differentiation to occur, whereas the expression of Myf5 and MRF4 act 
functionally superfluous transcription factors for the differentiation process.  It has also 
been hypothesized that the early expression of MyoD acts to “prime” the myoblast for 
differentiation as well as increase the expression of myogenin, whereas myogenin 
subsequently acts to induce the expression of muscle-specific structural genes [i.e., genes 
such as the three myosin heavy chain isoforms which contain E box sequences in their 
upstream promoter regions [82]] [81].  In regards to MyoD “priming” myoblasts for 
differentiation, there is ample evidence to suggest that MyoD: 1) induces the expression 
of pRb [80] and p21Cip1 [83], and 2) binds to p21Cip1, p27Kip1, and p57Kip2 in such a way 
as to increase their inhibitory action against cdks [68].  Likewise, there is other evidence 
to suggest that myogenin is more highly expressed in and regulates the expression of 
muscle-specific genes in slow oxidative fibers, whereas MyoD assumes this role in fast 




particular interest to examine the expression patterns of MyoD and myogenin following 
an exercise stimulus when interested in detecting the presence of differentiation events. 
Satellite cell fusion.  The fusion of differentiated myoblasts to pre-existing muscle 
fibers is perhaps the least understood process of satellite cell physiology.  In this regard, 
Jansen and Pavlath stated in a 2008 review article on the topic that, “many aspects of 
mammalian myoblast fusion remain a mystery” [85].  Rare data in the form of a classical 
time-lapse TEM- and fluorescent-based microscopic study [86] has delineated various 
phenotypic patterns that occur in myoblasts prior to fusion with other muscle cells 
including: 1) a build-up of cytoplasmic vesicles in myoblasts that are in close proximity 
to the region where fusion occurs, 2) the disappearance of extracellular, membrane-bound 
proteins and glycoproteins between the sarcolemma interface of the fusing cells, and 3) 
an internal structural protein breakdown preceding fusion followed by the reorganization 
and incorporation of these proteins into the complex protein lattice of the mature muscle 
following fusion.  Elucidating explicit myoblast-borne genes and/or paracrine/endocrine 
signals that regulate these processes have been proven less fruitful, although Jansen and 
Pavlath provide evidence (i.e., genetic knock-down and antibody interference studies in 
culture) to suggest that proteins expressed in and present on the sarcolemma of 
differentiated myoblasts may act to bind to cognate receptors present on post-mitotic 
fibers and initiate membrane union.  These proteins include M-cadherin, NCAM, 
integrin-beta1, the urokinase plasminogen activator receptor/serine proteinase urokinase 
plasminogen activator/plasminogen activator inhibitor-1 complex, glucose-related protein 




facets of myoblast-myofiber fusion remain to be determined and, therefore, are beyond 
the scope of the current investigation. 
Other signaling pathways. As a side, it is also important to briefly mention other 
prominent pathways that are synonymously active with satellite cell activity.  The Notch 
signaling pathway has been suggested to be involved in preventing precocious myoblast 
differentiation as evidenced in primary human satellite cell cultures, albeit the role of 
Notch receptors (Notch1, Notch3), Notch ligands (Jagged1, Jagged2, Delta-like1), Notch 
pathway inhibitors (Numb), and/or Notch-regulated genes (Hes1, Hes6) in this process 
has not been well established [87].  Likewise, bone morphogenic protein (BMP)/TGF-
beta signaling, which transduces intracellular signals through activated SMAD 
heterodimers, has been shown to inhibit myoblast differentiation [88], and inhibitors of 
this pathway (specifically the Twisted gastrulation and gremlin genes) are concomitantly 
upregulated during myoblast differentiation [77].  Finally, the canonical Wnt signaling 
pathway operates by the ligand binding of Wnt proteins to the Frizzled family of 
receptors which, in turn, inhibits the intracellular axin/GSK-3/APC complex that is 
known to promote the degradation of cytoplasmic beta-catenin proteins.  The subsequent 
accumulation of beta-catenin proteins following Frizzled receptor ligand binding leads to 
the increased nuclear localization of beta-catenin proteins whereby they act as 
transcription factors to promote the up-regulation of genes that favor satellite cell 
proliferation and inhibit myoblast differentiation [89].  Nonetheless, while Notch, 
BMP/TGF-beta, and Wnt signaling are indeed integral components of satellite cell 
physiology, elucidating the effects of aging and exercise on these pathways are beyond 





Effects of Exercise on Markers of Satellite Cell Activity 
Advanced time-lapse microscopy techniques have enabled multiple investigators 
to clearly demonstrate that different modes of exercise elicit an increase in satellite cell 
number (acutely) and post-mitotic myonuclear number (chronically) in mammalian 
skeletal muscle tissue (summarized in Table 1).  Conversely, sparse equivocal evidence 
does exist suggesting that a strenuous bout of endurance training in rats does not increase 
MyoD-positively stained cells at 0-72 hours post-exercise leading the authors to conclude 
that satellite cell activation did not occur at these time points [90].  Contrary to their 
hypothesis, it is possible that satellite cell proliferation occurred, but none of the 
proliferating myoblasts expressed MyoD and, therefore, did not commit to differentiation 
[68].  In this regard, Crameri et al. [65] later demonstrated that an eccentric exercise bout 
of leg extensions increased NCAM-positive cells (marker of proliferation) whereas there 
was no increase in the expression of myogenin and/or the neonatal isoform of the myosin 
heavy chain (markers of differentiation).  Thus, this evidence demonstrates the 
importance of probing explicit biomarkers when attempting to quantitate myoblast 
proliferation versus differentiation following an exercise stimulus. 
Investigators have also quantitated activity-related changes in muscle DNA 
concentrations without the use of fluorescent microscopy by treating mammalian muscle 
homogenates with fluorometric Hoechst 33258 dye.  For instance, Adams and Haddad 
[60] have allocated the aforementioned Hoechst dye method to demonstrate that 3 days of 
functionally overloading the plantaris muscles in rats yielded an approximate 100% 
increase in DNA without significant increases in muscle protein until day 7.  In order to 




to be mitotically inactive, increased DNA content in skeletal muscle cells [in this study] 
suggests activation of satellite cells.”  Further, our laboratory (unpublished observations 
which will be submitted for publication) has recently allocated the same Hoechst 
methodologies to demonstrate that an acute bout of conventional resistance training (i.e., 
9 sets of lower body exercise training using a lifting intensity of 80% 1RM) with or 
without pre-exercise nutrient ingestion in college-aged males: 1) increases muscle DNA 
content by 40% (p < 0.05), 2) increases the mRNA expression of CDK4 by 60% (p < 
0.05), and 3) decreases the mRNA expression of MYOD by 80% (p < 0.05) and P27KIP1 
by 640% (p < 0.001); all of these observations occurring 6 hours following exercise.  
Similar to the contentions of Adams and Haddad [60], our findings provide rare evidence 
(in particular our tandem DNA and cell cycle regulator gene expression analyses) to 
suggest that satellite cell activation and proliferation may be occurring at early post-
exercise time points following a conventional resistance exercise bout prior to 
differentiation events (depicted in Figure 4).  Therefore, previously published research 
has reported an increase in the DNA concentrations of muscle homogenates in tandem 
with other satellite cell markers following mechanical loading; with these findings also 
suggesting that satellite cell activity increases with mechanical loading.  
It is well established that a single bout of resistance exercise elicits an increase in 
the mRNA and/or protein expression of biomarkers indicative of satellite cell 
proliferation and differentiation.  For instance, a time-course study conducted by 
Psilander et al [57] demonstrated that MYOGENIN, MYOD, and MRF4 mRNA levels 
were elevated in human skeletal muscle by 100-400% at 0, 1, 2, 6, and 24 hours 




have been reported following an acute bout of resistance exercise including: 1) a 4-hour 
post-exercise increase in MYOD mRNA (2.0-fold) and MRF4 mRNA (1.4-fold) [91], 2) a 
12-24-hour post-exercise increase in MYOD mRNA (83%), MYOGENIN mRNA (3-fold), 
CYCLIN D1 mRNA (50%), and P21CIP1 mRNA (16-fold) [29], 3) a post-exercise 
increase of MRF4 mRNA (3.7- to 4.5-fold, 2–4 hours post), MYOD mRNA (5.8-fold, 8 
hours post), and MYOGENIN mRNA (2.6- and 3.5-fold, 8–12 hours post) [92], 4) a 24-
hour post-exercise decrease in p27Kip1 (–16% mRNA, –20% protein) and increase cyclin 
D1 mRNA (34%) [17], 5) a post-exercise increase MYOD mRNA (27% and 47%, 0 and 6 
hours post), MYOGENIN mRNA (24% and 46%, 0 and 6 hours post), MyoD protein 
(58% and 3.2-fold, 0 and 6 hours post), and myogenin protein (52% and 2.5-fold, 0 and 6 
hours post) [93].  Nonetheless, caution should be exercised when interpreting the 
aforementioned acute data due to the fact that a single bout of resistance exercise has 
been shown to only increase satellite cell proliferation 1, 4, and 8 days post-exercise (i.e., 
no study has detected myoblast differentiation/fusion occurring in acute settings) [16, 
65].  Taking this data into consideration, exercise-induced increases in MRF mRNA 
and/or protein expression following a single bout of exercise does not necessarily confer 
the formation of a differentiated myoblast. 
Limited evidence has studied the effects of sequential exercise on the mRNA and 
protein expression of satellite cell activity markers.  Costa et al. [94] demonstrated that 
six consecutive days of 90 eccentric leg extensor contractions in young males was shown 
to elicit: 1) a significant decrement in MYOD mRNA expression after two bouts and a 
return to basal levels after 6 bouts, 2) a significant increase in MYOGENIN mRNA after 




P21CIP1 mRNA after two bouts and a return to basal levels after 6 bouts, and 4) elicit a 
significant increase in KI-67 mRNA (a marker of satellite cell proliferation) after two 
bouts and a further increase after in this gene 6 bouts.  Interestingly, the authors 
commented upon these findings being peculiar given that the expression of differentiation 
markers peaked prior to the zenith of KI-67 mRNA expression.  Prior work by Haddad 
and Adams [95] similarly demonstrated that two sequential exercise bouts (i.e., an 
electrical stimulation protocol in rats) elicited greater responses in the mRNA expression 
of cellular proliferation (i.e., CYCLIN D1) and differentiation (i.e., MYOGENIN) indices 
at 15-40 hours post-exercise compared to a single exercise bout.  Further, these authors 
reported that the post-exercise phosphorylation/activation of p70S6 kinase was elevated 
for up to 40 hours following the second stimulation bout if these animals were allowed 
24-48 hours between sequential stimulation sessions, whereas one session alone did not 
elicit and increase in p70S6 kinase activation.  The latter finding is of the upmost 
relevance due to the fact that p70S6 kinase activates ribosomal protein S6 which, in turn, 
acts to increase the translation of mRNAs containing 5’ terminal oligopyrimidine tract (5’ 
TOP) sequences at the transcriptional start site including ribosomal-protein mRNAs.  The 
end result of this process includes an increase in ribosomal number or translational 
capacity.  In a recent editorial paper, George Thomas provides compelling evidence from 
bacteria, yeast, and amphibians to suggest that cellular growth must precede proliferation 
and differentiation due to the fact that a premature proliferative response in cells that 
have not adequately grown will yield progeny that are not able to differentiate [96].  In 
this regard, Thomas contends that ribosomal biogenesis (i.e., the translation of ribosomal-




given that protein synthetic machinery confers cellular growth by increasing the 
translation capacity of growing cells.  Thomas argues,  
“In a mitogen-stimulated cell, ribosome biogenesis is initially selectively 
upregulated, through the recruitment of ribosomal-protein mRNAs onto 
polysomes.  However, as more ribosomes are generated and the translational 
capacity increases, the pathway becomes desensitized favouring the translation of 
other mRNAs.  Thus, ribosomal-protein mRNAs first serve to increase protein 
synthesis capacity and the prevent the translation of mRNAs lacking a 5’ TOP, 
such as cell cycle regulators, until an appropriate pool of ribosomes have 
accumulated.” 
Finally, Dr. Esser’s group recently demonstrated that mTORC1 activation via the 
stimulation of differentiated myotubes with IGF-1 resulted in the concomitant elevation 
of cyclin D1 protein and rRNA concentrations [97].   In an attempt to integrate all of their 
findings, these authors explained that IGF-1 activates mTOR which: 1) increases the 
translation of cyclin D1 mRNA which acts in concert with cdk4 to increase the 
expression of rRNA by activating transcriptional activators upstream of rDNA genes, and 
2) increases the activation of p70S6 kinase and translation of ribosomal protein mRNAs.  
Thus, it becomes plausible that the IGF-1-mediated activation of p70S6 kinase, ribosomal 
protein S6 activation, and an “adequate” amount of ribosomal biogenesis may require 
multiple bouts of exercise to occur in satellite cells; an effect which may delay the 
translation of differentiation-regulating transcripts (i.e., MRF mRNAs) and the process of 
myogenesis itself.  Nonetheless, the aforementioned evidence again suggests that: 1) 




activity regulators in comparison to one exercise bout, 2) an increase in the satellite cell 
polyribosome population following one or multiple exercise bouts may be needed prior to 
MRF mRNAs being translated, and 3) the exercise-induced increases in MRF mRNA 
expression following a one or multiple bouts of exercise do not indicate the de novo 
formation and fusion of differentiated myoblasts to pre-existing myofibers.  Thus, it is 
imperative that other biomarkers of translational capacity (i.e., total RNA), proliferation 
(i.e., immunohistochemistry and/or DNA quantitation) and differentiation (i.e., 
immunohistochemistry, [DNA]: [protein] quantitation, and/or quantitating proteins 
indicative of differentiation) need to be assessed in tandem with the expression of cell 
cycle/differentiation-regulating transcripts to further delineate if these processes have 
occurred following exercise. 
 It is relevant to comment upon whether or not the exercise-induced expression of 
various cell cycle and differentiation regulators occurs from satellite cells alone versus 
post-mitotic fibers and satellite cells (as indicated in Figure 3).  The percent of myonuclei 
contributed from satellite cells to the total nuclei pool in skeletal muscle samples has 
been reported to be minimal.  In this regard, Karyn Esser and her research group [98] 
have contended that the post-exercise expression of myogenic (i.e., cyclins and MRFs) 
and anti-growth (i.e., cdk-inhibitors) mRNA transcripts likely originate from post-mitotic 
fibers due to the fact that satellite cell nuclei account for merely 1.8% of the total nuclei 
in the muscle bed compared to post-mitotic fiber nuclei which constitutes ~43% of the 
total nuclei pool.  To support their contention, the authors stated, “Therefore, if the cell 
cycle gene expression changes come from the subset of satellite cells that are activated 




them to be detectable in a homogenate from whole [muscle].”  Alternatively, these 
authors postulate that the expression of anti-growth genes (i.e., cdk-inhibitors, MRFs) 
occurs in post-mitotic myonuclei in order to “counter” the cellular proliferation genes 
(i.e., cyclins) being expressed from these same nuclei.  Further, these authors contend that 
the post-exercise increase in MRF expression from post-mitotic nuclei may occur to keep 
muscle cells in a differentiated, non-proliferative state.  In support of this hypothesis, 
Esser’s group has provided evidence to suggest that differentiated myotubes express 
CYCLIN D1 in culture when treated with mitogenic culture media [97].  To counter this 
argument, however, there is recent cell culture data to suggest that the expression of 
cyclins minimally occurs in terminally-differentiated fibers maintained in differentiation 
media [99].  Likewise, a recent study allocated in situ RNA hybridization techniques, 
which uses microscopic methods to localize mRNA transcripts in different cellular 
regions, to demonstrate that none of the MRFs are expressed in the mature myofibers of 
mdx mice and are, instead, highly expressed in proliferating satellite cells [100].  Taking 
all of this data into consideration it seems as if the mRNA and protein expression of 
genes that control cellular proliferation and differentiation are expressed and localized in 
satellite cells, respectively, albeit the aforementioned equivocal evidence deems it 
obligatory to perform future research using in situ RNA hybridization techniques or 
FACS-based methods following an exercise stimulus to unequivocally delineate which 







Effects of Aging on the Expression of MRFs and Markers of Satellite Cell Activity at Rest 
and following Resistance Exercise 
 
Several histological and molecular manifestations accompany muscle aging.  A 
classical cadaver study performed by Dr. Jan Lexell demonstrated that vastus lateralis 
fiber number and muscle size are diminished in older versus younger male humans 
(364,000 versus 478,000 fibers, p < 0.01; gross muscle size was18% smaller, p < 0.01), 
providing strong evidence that muscle fibers unexplainably disappear with aging.  
Likewise, Haddad and Adams [22] have determined that rodent muscle, while containing 
similar total protein content, possess a significantly lower amount of myofibrillar protein 
content when compared to younger counterparts.  Finally, satellite cell numbers are 
purportedly reduced in older humans [specifically, Verdijk et al. [3] reported that type II 
fiber satellite cells are 45% lower in older humans] and rodents [101, 102].  In regards to 
the latter findings, in vivo evidence suggests that satellite cells undergo 1-2 divisions 
prior to committing to differentiation [103]; this being a phenomenon which advocates 
the notion that satellite cell pools may become mitotically exhausted over a lifetime.  
However, the evidence presented below also suggests that age-related decrements in 
satellite cell number and proliferative potential are likely caused by other molecular 
mechanisms as well. 
Although the mechanisms leading to decrements in myofibrillar protein and 
myofiber number are poorly understood, it has been hypothesized that decrements in 
satellite cell activity with aging [i.e., proliferation [104] and differentiation [19, 105]] 
may serve as the causal hub of these events.  In this regard, Gopinath and Rando [106] 




alterations in circulatory factors (i.e., leukocytes as well as known and unknown 
hormones and growth factors) as well as the extracellular matrix surrounding satellite 
cells occurs with aging.  In support of the former contention, Rando’s research group 
conducted an experiment using heterochronic parabiosis whereby pairs of young and old 
mice were surgically “combined” to share a common circulatory system [107].  
Interestingly, performing this procedure over a 5-week period significantly enhanced the 
proliferative capacity of satellite cells of older mice 24 hours following muscle injury in 
culture.  When explaining these findings, the authors stated, 
“Our experiments suggest that there are systemic factors that can modulate the 
molecular signaling pathways critical to the activation of tissue-specific 
progenitor cells, and that the systemic environment of a young animal is one that 
promotes successful regeneration, whereas that of an older animal either fails to 
promote or actively inhibits successful tissue regeneration.” 
Contrary to the aforementioned hypothesis, recent evidence also suggests that co-
culturing satellite cells from young rats on tissue dishes coated with the extracellular 
matrix extract from old rats actually enhances proliferation capabilities [108].  These 
authors deemed as these findings as surprising and postulated that they may be due to the 
lower efficiency at which extracellular matrix components can be isolated from older 
rats; this being a methodological limitation which may have obscured their findings.  
Nonetheless, there is equivocal evidence to suggest that mitotically senescent fibroblasts 
present in the extracellular matrix of skeletal muscle in older species secrete elevated 
levels of proinflammatory cytokines (i.e., TNF-alpha and IL-1beta are examples) which 




Contrary to the abovementioned age-associated alterations in circulating and 
extracellular matrix factors, there is convincing evidence to also suggest that the age-
associated decrement in the expression of muscle-derived IGF-1 variants is causally 
linked to satellite cell dysfunction due to its integral role in satellite cell activation.  In 
this regard, Machida and Booth [111] authored a review article on the topic stating, 
“…satellite cells in skeletal muscle of [old] rats are in sufficient quantity, but inactive as 
a result of lack of some endogenous growth factors, possibly including IGF-1.”  Data 
from Booth’s laboratory demonstrating that IGF-1 administration to aged rats 
substantially increased satellite cell proliferation supports this hypothesis [112].  
Furthermore, past literature has determined that older rodents and humans exhibit a 
decrement in MGF and/or IGF-1EA mRNA expression following an acute bout of 
exercise [10, 15, 22], and limited human evidence [15, 23] has suggested that the acute 
post-exercise decrement in IGF-1 mRNA expression is associated with a long-term 
decrement in phenotypic adaptations (i.e., increases in muscle CSA) accrued from 
resistance training.  Finally, our laboratory has recently determined that the baseline 
myogenic expression of IGF-IEA mRNA is significantly lower in older versus younger 
humans during resting states [113].  Taking all of this evidence in consideration, it would 
be insightful to determine if a potential age-related decrement in basal and post-exercise 
MGF and IGF-1Ea mRNA/protein expression is associated with a lag in cell cycle 
regulators and markers of de novo satellite cell replication during a series of resistance 
training sessions. 
In regards to skeletal muscle aging, limited evidence suggests that MRF mRNA 




myogenin ↑44%) [18] are generally higher in the skeletal muscle of older individuals; an 
effect which may be due to aging skeletal muscle attempting ameliorate muscle loss 
through the compensatory expression of these myogenic genes [18].  Conversely, 
intramuscular protein concentrations of cell cycle regulators (i.e., cyclin D1, cyclin B1, 
and p27Kip1) have not been shown to be influenced by human aging [18], albeit a recent 
investigation by Lees et al [19] reported a 50% decrement in p27Kip1 protein levels from 
older cultured rat satellite cells.  Likewise, a similar study demonstrated that a decrement 
in the P57KIP2 and P21CIP1 genes occurs in the skeletal muscle of mice during aging; an 
effect which may contribute to a diminished capability of satellite cells to differentiate 
[30].  Interestingly, only one study to date [17] has examined the effects of resistance 
training on the mRNA expression of selected cyclins, cdks, cdk-inhibitors, and MRFs 
between young and older humans 24 hours following a single bout of conventional 
resistance exercise.  These authors reported that the mRNA expression patterns 
significantly decreased for P27KIP1 (-16%) and increased for CYCLIN D1 (34%) and 
MGF (49%) in both age groups.  However, a post hoc analysis revealed a significant 
increase in MGF after exercise in young men only (91%).  Hence, it is apparent that there 
are: 1) loading-mediated effects on MGF, cdk, cyclins, cdk-inhibitor and MRF expression 
patterns following exercise, 2) “older” satellite cells may express less cdk-inhibitors at 
and more MRFs baseline, and 3) older skeletal muscle tissue may express less MGF 
following mechanical loading.  In this regard, data from the current investigation 
provides rare evidence of these potential patterns 24-48 hours following three sequential 






Concluding Remarks and Significance of the Current Study 
Based upon the aforementioned literature, it is apparent that exercise is capable of 
increasing  the number of resident satellite cells in the muscle bed of younger and older 
individuals, albeit many of these investigations have employed non-conventional and 
impractical means of mechanical loading (i.e., eccentric exercise).  Furthermore, while 
the various molecular mechanisms that govern the cell cycle have been elucidated, 
evidence is lacking in regards to the molecular mechanisms that decrease satellite cell 
replication capabilities in older versus younger individuals following conventional 
resistance exercise.  The transient post-exercise myogenic expression of MGF has been 
shown to be impaired in older versus humans younger [10, 17], albeit these studies have 
not examined the plausible downstream manifestations that may occur in response to this 
age-divergent mechanism.  In this regard, the current investigation determined 
MGF/IGF-1EA, CYCLIN D1, cdk, cdk-inhibitor, and MRF/IGF-1EA mRNA expression 
patterns as well as the appearance of markers signifying the de novo synthesis of satellite 
cells prior to and following one week of conventional resistance exercise.  As mentioned 
previously, the findings from this study warrants future research in determining the 
potential epigenetic modifications that may occur in aging satellite cells and/or post 









Based on the findings of Kim et al. [17], which determined the 24-hour post-
exercise changes in MGF mRNA expression to be significantly altered between ages 
(young = 1.03 ± 0.11 AUs, old = 0.86 ± 0.11 AUs), the sample size calculations for a 
between-subjects study design yielded a minimum sample size of n = 7 for each group in 
order to attain a statistical power of 0.80.  Therefore, to minimize the probability of 
making a type II error, 10 older (60-75 y) and 10 younger (18-25 y) males who were not 
currently participating in any form of resistance training with their lower bodies were 
recruited for this study.  Eligibility inclusion criteria included the following: 1) 
participants were apparently healthy but cannot have participated in a structured lower-
body resistance exercise regimen consistently (i.e., at least one time per week) one year 
prior to participation in this study, 2) participants were instructed to abstain from 
smoking, alcohol, tobacco or caffeine for the duration of the study, 3) participants cannot 
have consumed ergogenic nutritional supplements for at least three months prior to the 
start of the study, 4) participants could not be affected with metabolic disorders including 
heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism, 5)  participants 
could not have a history of pulmonary disease, hypertension, hepatorenal disease, clotting 
disorders, musculoskeletal disorders, neuromuscular/neurological diseases, autoimmune 
disease, cancer, peptic ulcers, or anemia, 6) participants could not have any orthopedic 
problems (e.g., previous surgery, joint replacements, etc.) or cannot have been previously 




training sessions, 7) participants could not be taking prescription medications indicated 
for heart, pulmonary, anti-coagulant, anti-hypertensive, psychotropic, 
neuromuscular/neurological, or androgenic dysfunctions, 8) participants could not have 
any absolute or relative contraindication for exercise testing as outlined by the American 
College of Sports Medicine (listed in the delimitations section).  This study was 
submitted the University of Oklahoma Health Sciences Center Institutional Review 
Boards for Human Subjects for approval and all participants completed a written 
informed consent form (Appendix D) as well as a pre-study health and exercise status 
questionnaire (Appendix E).  All participants who were the older group were required to 
provide written medical clearance from their primary care physician using the form 
provided (Appendix F). 
 
Research Design 
An overview of the research design is presented in Figure 5.  A two-way [age 
(young vs old males) x testing session (T1-T4)] repeated measures design was used to 
determine the effects of age and repeated bouts of conventional lower body resistance 
training on markers indicative of satellite cell proliferation (i.e., muscle [DNA], [c-met], 
[PCNA], and the fold-change expression in CYCLIN D1, CDK4, CDK2 mRNA 
transcripts),  differentiation (i.e., [myofibrillar protein], [total protein], [total 
protein]:[DNA], the fold-change expression in MHCEMB and MYOD mRNA transcripts), 
and growth factor expression (i.e., muscle [IGF-1], and the fold-change in MGF and IGF-
1EA mRNA transcripts).  All participants visited the laboratory seven times (T1 = day 0, 




12).  Prior to the first visit, participants were verbally screened to ensure that each person 
met the entrance criteria.  Furthermore, participants completed the informed consent and 
health and history questionnaire prior to first visit.  During the first visit (T1), participants 
reported to the laboratory between 0600 and 0900 following a 12-hour fast and had a 
percutaneous muscle biopsy obtained from the lateral aspect (i.e., vastus lateralis) of 
their thigh.  Following the biopsy, participants warmed up for 5 minutes on a cycle 
ergometer (i.e., 60 r.p.m. at a self-selected intensity) and performed 1RM strength testing 
on bilateral leg press, hack squat, leg extension machines using guidelines established by 
the National Strength and Conditioning Association [114].  For the leg press and hack 
squat exercises, a successful repetition required that each participant attained a 90º knee 
flexion at the bottom (eccentric) portion of the repetiton which was visually gauged by a 
laboratory technician.  Two days following T1, participants returned to the laboratory for 
FAM1 whereby they warmed up for 5 minutes of a cycle ergometer and performed 2 sets 
of 10 repetitions at a lifting intensity of 60% 1RM for each of the three lower-body 
exercises with 2-3 minutes alotted between sets.  Two days following FAM1, participants 
returned to the laboratory for FAM2 whereby they warmed up for 5 minutes of a cycle 
ergometer and performed 2 sets of 10 repetitions at a lifting intensity of 70% 1RM for 
each of the three lower-body exercises with 2-3 minutes alotted between sets.  The 
purposes of FAM1 and FAM2 were to ensure that participants were gradually eased into 
the training protocol employed during workout 1 through T3, and to minimize the 
delayed onset of muscle soreness with these untrained participants which has been 
employed by Bamman and colleagues [18].  Two days following FAM2, participants 




warmed up for 5 minutes on a bicycle ergometer, and performed 3 sets of 10 repetitions 
at a lifting intensity of 80% 1RM for each of the three lower-body exercises with 2-3 
minutes alotted between sets.  Two days following workout 1, participants reported to the 
laboratory for T2 between 0600 and 0900 following a 12-hour fast, donated a second 
muscle biopsy from the opposite leg of T1, warmed up for 5 minutes of a cycle 
ergometer, and performed 3 sets of 10 repetitions at a lifting intensity of 80% 1RM for 
each of the three lower-body exercises with 2-3 minutes alotted between sets.  Two days 
following T2, participants reported to the laboratory for T3 between 0600 and 0900 
following a 12-hour fast, donated a third muscle biopsy from the opposite leg of T2, 
warmed up for 5 minutes of a cycle ergometer, and performed 3 sets of 10 repetitions at a 
lifting intensity of 80% 1RM for each of the three lower-body exercises with 2-3 minutes 
alotted between sets.  Finally, one day following T3, participants reported the laboratory 
for T4 between 0600 and 0900 following a 12-hour fast and donated a fourth muscle 
biopsy from the opposite leg of T3.  It should be noted that all participants were verbally 
encouraged during each set by a laboratory technician.  As mentioned previously, all leg 
press and hack squat repetitions required that each participant attains 90º knee flexion at 
the bottom (eccentric) portion of the repetiton which was visually gauged by a laboratory 
technician.  Furthermore, it should be noted that participants were able to complete all 
workouts without detracting weight from their prescribed lifting volumes.  
 
Variables 
The independent variable in this study is age group (i.e., younger vs older).  The 




time point and served as dependent variables.  Note that the following descriptions have 
been adapted from Chapter II of this paper. 
General Biomarkers of Satellite Cell Differentiation 
1. Muscle [DNA]. For T1-T4 for each participant; a post-exercise increase in this marker 
indicated that DNA synthesis has occurred in the muscle bed; potentially from 
proliferating myoblasts.  Wong and Booth [115] demonstrated that DNA content from 
the gastrocnemius significantly increased by 20% (p < 0.05) 12 and 36 hours 
following exercise in rats that performed 24 weighted concentric contractions.  While 
these authors attributed these increases to an increase in satellite cell activity, they 
also stated that infiltrating leukocytes following exercise may have also contributed to 
increases in DNA content.  A follow-up study performed by Malm et al. [116] used 
immunofluorescent microscopy to determine if eccentric loading increased the 
infiltration of leukocytes into skeletal muscle at various post-exercise time points.  
Their findings suggest that satellite cell activation (i.e., CD56+ cells) increased 271% 
(p < 0.05) 48 hours following exercise.  Likewise, macrophage infiltration (CD163+ 
cells) also increased and was the predominant signal of post-exercise leukocyte 
infiltration in the muscle bed at this time point.  Therefore, protein homogenates from 
each biopsy were also probed for CD163 to confirm that post-exercise elevations in 
DNA content were not predominantly due to infiltrating monocytes/macrophages. 
2.  Muscle [myofibrillar protein]. For T1-T4 for each participant; the myofibrillar 
protein pool includes sarcomeric proteins such as the various isoforms of myosin, 
actin, troponin, nebulin, titin, etc.  Increases in myofibrillar protein may partially 




predominant limitation of quantitating this pool using our methods is the non-
discriminatory detection of newly synthesized myofibrillar protein that may arise 
from pre-existing fibers.  In this regard, other genetic and proteomic markers (i.e., 
fold-changes in MyoD and MHCemb mRNA transcript expression) were analyzed to 
further delineate if myoblast differentiation/fusion potentially occurred. 
3. Muscle [total protein]. For T1-T4 for each participant; the total muscle protein pool 
includes myofibrillar, sarcoplasmic, mitochondrial, and nuclear sub-fractions as well 
as extracellular matrix proteins.  Again, increases in this biomarker following 
exercise may have signified an increase in satellite cell differentiation and fusion 
events although the aforementioned limitations still exist. 
Muscle mRNA Transcripts 
In a recent review article [117] geneticist Dr. Frank Booth states, “As a general 
rule, changes in [mRNA] and [protein] encoded by these mRNAs occur in the same 
direction.”  Therefore, it is my contention that detecting an alteration in the post-exercise 
mRNA expression of cell cycle regulators in concert with other molecular markers (i.e., 
skeletal muscle [DNA], [c-met], and [PCNA]) provided invaluable insight in regards to 
which one of the below-mentioned targets were dysregulated with aging. 
1. MGF. For T1-T4 for each participant; this gene contains a 52 base pair insert relative 
to the systemic IGF-1EA gene and, thus, encodes the IGF-1EC/MGF muscle-specific 
peptide that has an altered C-terminus compared to the IGF-1Ea peptide.  The MGF 
peptide has been shown to operate through IGF-1 receptor-independent pathway to 
induce satellite cell proliferation, and its mRNA expression is thought to occur 




2. IGF-1EA. For T1-T4 for each participant; this mRNA encodes the systemic IGF-1 
peptide which is thought to be synthesized and released from exercised muscle in a 
delayed fashion following exercise in order to induce a subset of proliferating 
myoblasts to differentiate [21]. 
3. CDK4. For T1-T4 for each participant; this mRNA encodes the catalytic portion of 
cdk4-cyclin D1 heterodimer that hyperphosphorylates pRb and facilitates satellite cell 
entry into the S phase. 
4. CDK2. For T1-T4 for each participant; this mRNA encodes the catalytic portion of 
cdk2-cyclin E heterodimer that irreversibly hyperphosphorylates pRb and allows the 
replicating satellite cell to finish the S phase. 
5. CYCLIN D1. For T1-T4 for each participant; this mRNA encodes the regulatory 
portion of cdk4/6-cyclin D1 complexes that hyperphosphorylate pRb proteins 
allowing the cell to enter the S phase.  Furthermore, IGF-1 has been shown to 
stimulate the mRNA and protein expression of this cell cycle regulator [27, 97].  
6. MYOD. For T1-T4 for each participant; this mRNA encodes the MyoD myogenic 
regulatory transcription factor which is expressed in satellite cells that are committed 
to differentiation. 
7. MHCEMB. For T1-T4 for each participant; this myosin isoform has been shown to be 
expressed in very small regenerating fibers and is thought to signify the presence of 
newly differentiated myotubes that fuse to pre-existing muscle fibers [31]. 
8.  P21CIP1. For T1-T4 for each participant; this mRNA encodes the “shotgun” p21Cip1 
cdk-inhibitor which binds to cdk-cyclin heterodimers to inhibit their activity; an 




is evidence to also suggest that p21Cip1 may actually confer the stability of G1-phase 
cyclins and, thus, facilitate the cell cycle. 
9. P27KIP1. For T1-T4 for each participant; this mRNA encodes the “shotgun” p27Kip1 
cdk-inhibitor which binds to cdk-cyclin heterodimers to inhibit their activity; an 
effect which facilitates cell cycle exit and is needed for differentiation to occur. 
10.  Beta-2 microglobulin 9(B2M) and 28s rRNA (28S). For T1-T4 for each participant; 
these mRNAs are stably expressed prior to and following exercise as well as across 
aging males which makes it a great candidate as a normalizing control when 
performing gene expression experiments. 
Muscle Proteins  
1. Muscle [c-met]. For T1-T4 for each participant; this protein is explicitly expressed in 
mitotically quiescent satellite cells and proliferating myoblasts [55].  Observing a 
concomitant increase in this protein with increases in DNA suggested that satellite 
cell content is likely increasing following the exercise intervention. 
2. Muscle [PCNA]. For T1-T4 for each participant; this protein is explicitly expressed in 
mitotically active satellite cells and signifies the presence of myoblasts undergoing 
DNA synthesis. 
3. Muscle [IGF-1]. For T1-T4 for each participant; this growth factor is the resultant 
peptide of MGF and IGF-1EA translation (i.e., manufactured antibodies cannot 
distinguish between the MGF and IGF-IEa isotypes).  Nonetheless, an increase in the 
concentration of this growth factor in skeletal muscle following a series of exercise 







1. Leg press/hack squat combo (Model #:  HLS – 160, Yukon Fitness Equipment, 
Cleveland, OH). This machine was used to 1RM test participants for the leg press and 
hack squat exercises.  Further, this machine was used to train participants during 
subsequent workouts for these respective exercises. 
2. Leg extension machine (Model #:  Nautilus NT 1220 Rotary Leg Extension/Curl 
Station, Nautilus Inc., Vancouver, WA). This machine was used to 1RM test 
participants for the leg extension exercise.  Further, this machine was used to train 
participants during subsequent workouts for this respective exercise. 
3. Fluorometer (Model #:  Versafluor Fluorometer, Bio-Rad Laboratories, Hercules, 
CA).  This machine was used to quantitate DNA from crude muscle homogenates 
with Hoechst 33258 dye (Sigma, St Louis, MO) being used as the probe. 
4. Automated electrophoresis platform (Model #: Experion Electrophoresis Station, 
BioRad Laboratories, Hercules, CA). This machine was used to randomly test RNA 
quality of a subset of samples from the aqueous fraction of the Tri reagent (Sigma, St. 
Louis, MO) homogenates. 
5. 96 well spectrophotometer (Model #: Model 680, Bio-Rad Laboratories). This 
machine was used to quantitate total protein and myofibrillar protein from crude 
muscle homogenates with Bradford dye (Bio-Rad Laboratories) being used as the 
probe. 
6. Thermal cycler (Model #: MyiQ Optics Model, Bio-Rad Laboratories). This machine 




GOIs from reverse transcribed mRNA present in the total RNA pool (a.k.a., 
complimentary DNA or cDNA) with SYBR green (Bio-Rad Laboratories) and gene-
specific primers (Integrated DNA Technologies, Coralville, IA) being used as probes. 
7. Electrophoresis cell (Model #: Criterion Cell, Bio-Rad Laboratories). This machine 
was used to separate proteins from the cell lysis homogenates based upon molecular 
mass.  Following this step, muscle-specific proteins (i.e., c-met, PCNA, IGF-1) were 
electrotransferred onto nitrocellulose membranes, probed for transfer efficiency using 
Ponceau S stain (Sigma, St. Louis, MO), and these proteins were immunoprobed 
using protein-specific antibodies (c-met, PCNA: Cell Signaling Technology Inc., 
Manvers, MA; IGF-1: Abcam, Cambridge, MA) and enhanced chemiluminescent 
reagent (Bio-Rad Laboratories) 
8. Electrotransfer cell (Model #: Criterion Blotter, Bio-Rad Laboratories). This 
machine was used to transfer proteins from SDS-PAGE gels to nitrocellulose 
membranes as mentioned above. 
9. Gel documentation system (Model #: Chemi Doc XRS, Bio-Rad). This machine was 
used to detect and quantitate protein banding to determine muscle-specific protein 
expression patterns. 
 
Percutaneous Muscle Biopsies   
Biopsies were obtained during T1 (baseline), prior to exercise during T2 (48 
hours following workout 1) and T3 (48 hours following workout 2), and during T4 (24 
hours following workout 3). All biopsies were collected halfway between the hip and 




damage [116], biopsies were collected from alternating legs during subsequent testing 
sessions in such a way that two muscle collections occurred from each leg.  It should be 
noted that previous research examining an exercised versus non-exercised leg in the same 
participants has revealed that 9 weeks of unilateral leg extensor resistance training has no 
effect on satellite cell activity in the non-exercised leg [118].  The multiple muscle 
collection procedures were standardized by using anatomical palpation, visual 
identification of the previous biopsy, and depth markings on the needle.  Prior to each 
biopsy, the area was shaven clean of leg hair, and a small area of the skin approximately 
2 cm in diameter was anesthesized with a 1.5 ml subcutaneous injection of 1% Lidocaine 
HCl.  Following 15 minutes, the biopsy area was sterilized in a circular fashion to a 3-
inch radius with an antiseptic soap (i.e., betadine), an incision approximately one-quarter 
of an inch was made using a sterile razor, and a sterilized 5-mm Bergstrom biopsy needle 
with a suction apparatus applied to its end was inserted into the pilot hole.  Suction was 
applied and the muscle tissue was excised in a double-chop fasion.  Immediately 
following the biopsy, the muscle tissue was removed from the needle using sterile 
instruments, the collected tissue was placed into a blindly-labeled cryogenic storage tube, 
and the tube was dropped in storage container containing liquid nitrogen (i.e., flash 
frozen).  Samples were then transferred for long-term storage into a -80 C freezer until 
completion of the study for biochemical analyses.  
 
Muscle [DNA] Determination 
Using the fluorescent Hoechst dye, increases in muscle [DNA] due to increases in 




Briefly, a section of muscle from each time point per participant was weighed (~20 mg) 
and homogenized on ice with 400-700 μl of cell lysis buffer (250 mM sucrose, 100 mM 
KCl, 5 mM EDTA, 10 mM Tris-HCl, pH 6.8) using a tight-fitting pestle.  For muscle 
DNA determination, 50 μl of cell lysis crude homogenate was assayed with 1 ml of a 
fluorometric dye (Hoechst 33258 dye; Sigma, St Louis, MO), and the fluorescent signal 
was detected using a single cuvette-based fluorometer (Bio-Rad Laboratories).  The 
buffer for this assay contains a high salt concentration (2 M NaCl, 1 mM EDTA, 10 mM 
Tris-HCl, pH 7.4), and under the high salt condition the dye binds only to the DNA and 
not the RNA component in the homogenate.  Further, this dye is reported to have a high 
affinity for AT-rich sequences in the minor groove of double-stranded DNA and, when 
excited at 360 nm, emits a fluorescent signal that is detectable with a 460 nm filter.  This 
method has been successfully employed by Adams and Haddad [60] to detect changes in 
DNA content within the skeletal muscle of rats following a mechanical loading protocol.  
The predominant limitation to this method, as proposed by Booth [119], includes 
quantifying DNA from other cells in the muscle bed including stromal vascular cell lines 
(i.e., fibroblasts, smooth muscle, epithelial cells) infiltrating leukocytes, intramuscular fat 
pads as well as DNA from pre-existing muscle.  To minimize this interference, excess 
adipose tissue, connective tissue, and blood cell infiltrates were removed from the muscle 
samples dedicated to this analysis using sterile instruments.  Similarly, the presence of 
protein markers specific to infiltrating macrophages (i.e., CD163) using dot-blotting 
techniques were performed to examine if repeated bouts of exercise increase the 
accumulation of these cells in the muscle bed.  Unknown [DNA] values were compared 




assays were performed in duplicate.  Coefficient of variation values between duplicates 
averaged 3.3%. 
 
Muscle [Total Protein] and [Myofibrillar Protein] Determination 
For muscle [total protein] determination, 50 µl of the aforementioned cell lysis 
crude homogenate that was sampled for DNA was diluted with 350 µl of dH2O and 10 µl 
of this total protein diluent was assayed with 200 µl Bradford reagent (Bio-Rad 
Laboratories).  This method has been successfully employed by Haddad and Adams [22] 
to detect age-related differences of [total protein] within the skeletal muscle of rats.  
Absorbance values for each sample were read using a 595 nm filter in a 96 well 
spectrophotometer (Bio-Rad Laboratories), unknown [total protein] values were 
compared to known [total protein] values using a standard curve method with bovine 
serum albumin, and all assays were performed in duplicate.  Coefficient of variation CT 
values between duplicates averaged to be less than 10%. 
For muscle [myofibrillar protein] determination, the remainder of the 
aforementioned crude homogenate that was sampled for [DNA] and [total protein] was 
centrifuged at 5,000 revolutions per minute (RPM) at 4 C for 10 minutes.  The resultant 
supernatant was discarded and the resultant pellet was treated with 1 ml of myofibril 
protein extraction buffer 2 (175 mM KCl, 2 mM EDTA, 0.5% Triton-X 100, 10 mM Tris 
HCl, pH 6.8) vortexed rigorously, and centrifuged at 5,000 RPM at 4 C for 10 minutes.  
The resultant supernatant was again discarded and the resultant pellet was treated with 1 
ml of myofibril protein extraction buffer 3 (150 mM KCl, 10 mM Tris HCl, pH 7.0) 




supernatant was again discarded and the resultant pellet (made up of pure myofibrils) was 
suspended in 500 µl of myofibril protein extraction buffer 3 (150 mM KCl, 10 mM Tris 
HCl, pH 7.0).  Fifty (50) µl of the suspended myofibril solution from each sample was 
assayed using 1 ml of Bradford reagent (Bio-Rad Laboratories), and absorbance values 
for each sample was read using a 595 nm filter in a single cuvette spectrophotometer 
(Bio-Rad Laboratories).  This method has been successfully employed by Haddad and 
Adams [22] to detect age-related differences of [myofibrillar protein] within the skeletal 
muscle of rats.  Unknown [myofibrillar protein] values were compared to known 
[protein] values using a standard curve method with bovine serum albumin, and all assays 
were performed in duplicate.  Coefficient of variation CT values between duplicates 
averaged to be less than 10%. 
  
Muscle [Total RNA] Determination 
Briefly, a second section of muscle from each time point per participant was 
weighed (~30 mg) and homogenized using 500 µl of Tri reagent (Sigma Chemical Co., 
St. Louis, MO) which contains a monophasic solution of phenol and guanidine 
isothiocyanate.  Following thorough homogenization, samples were centrifuged at 12,000 
RPM at 4 C for 10 minutes, and the resulting supernatant (free of insoluble protein and 
high molecular weight DNA) was poured into a new microcentrifuge tube.  
Approximately 100 µl of chloroform was added to these samples, samples were vortexed 
for 15 seconds, and samples were incubated at room temperature for 10 minutes.  
Samples were then centrifuged at 12,000 revolutions per minute at 4 C for 15 minutes.  




microcentrifuge tube and 250 µl of 100% isopropanol was used to precipitate the RNA 
from the aqueous phase.  Samples were then centrifuged at 12,000 RPM at 4 C for 15 
minutes to form a RNA pellet and the resulting supernatant was disposed.  The RNA 
pellet was then exposed to a subsequent 750 µl 75% ethanol wash,  centrifuged at 12,000 
RPM at 4 C for 5 minutes, and the resulting supernatant was disposed.  Finally, the 
resultant air-dried RNA pellet was dissolved in 50 µl of RNase-free water with repeated 
pipetting/vortexing.  The diluted RNA samples were then stored at -80 C until later 
analyses. 
An aliquot of total RNA per sample was diluted 25-fold and concentrations as 
well as RNA purity for each sample determined using a spectrophotometer (Bio-Rad 
Laboratories).  The average coefficient of variation between duplicates was 9.0%.  A 
random subset of RNA samples were tested for RNA quality using the proprietary High 
Sensitivity RNA analysis kit with the Experion Automated Electrophoresis platform 
(Bio-Rad Laboratories) (Figure 6).  This method separates and quantitates mRNA 
ranging from 50-6,000 nucleotides in length using a laser-excitable RNA stain and RNA 
ladder provided by the manufacturer.  Furthermore, this procedure has been previously 
shown in our laboratory to yield un-degraded RNA, free of DNA and proteins as 
indicated by prominent 28S and 18S ribosomal RNA bands.  The preparation of reagents 
and the RNA ladder were performed according to the manufacturer’s instructions.  
Furthermore, all RNA samples and the RNA ladder were thawed on ice during the assay 






Real-Time PCR to Detect Pre- and Post-Exercise Expression of Genes of Interest 
Following total RNA concentration determination, 50 ng of total RNA was 
reverse transcribed to synthesize cDNA.  For each sample, a reverse transcription 
reaction mixture [40 μl total: 1) 50 ng of total cellular RNA diluted to 30 μl with RNase-
free water, 2) 8 μl 5x reverse transcription buffer, a dNTP mixture containing dATP, 
dCTP, dGTP, and dTTP, MgCl2, RNase inhibitor, an oligo(dT)15 primer, and 3) 2 μl of 
MMLV reverse transcriptase enzyme (Bio-Rad Laboratories)] were incubated at 42 C for 
40 minutes, heated to 85 C for 5 minutes, and then quick-chilled on ice yielding the 
cDNA product.  Finally, 80 μl of RNase-free water was added to the resultant volume to 
bring the cDNA solutions up to 120 μl, and cDNA solutions were subsequently frozen at 
-80 C until semi-quantitative real-time PCR was performed. 
Forward and reverse oligonucleotide primer pairs were constructed using 
commercially available Beacon Designer software (Bio-Rad Laboratories) and 
synthesized through a commercial manufacturer (Integrated DNA Technologies, 
Coralville, IA) (Table 2).  The arithmetic mean of B2M and 28S (B2M & 28S avg) 
mRNA was used as an internal reference for detecting the relative quantity of target 
mRNA due to the fact that our laboratory and others [120] have found these genes to be 
constitutively expressed after resistance exercise and during muscle aging.  Two (2) μl of 
cDNA were added to each of the separate PCR reactions for CDK4, CDK2, CYCLIN D1, 
MYOD, MYOGENIN, P21CIP1, P27KIP1, IGF-1EA, MGF, MHCEMB, B2M , and 28S and 
each PCR reaction contained the following mixtures: 12.5 μl of SYBR Green Supermix 
(Bio-Rad Laboratories) (100 mM KCl mixture, 40 mM Tris-HCl, 0.4 mM of each 




Green I, 20 nM fluorescein), 1.5 μl of sense and antisense gene-specific primers, and 7.5 
μl of nuclease-free dH2O.  The PCR reactions were amplified with a thermal cycler (Bio-
Rad Laboratories) whereby the amplification sequence involved an initial 10-minute 
cycle at 95 C to activate the Taq polymerase followed by a 40-cycle period with a 
denaturation step at 95 C for 15 seconds and primer annealing/extension step at 55 C for 
45 seconds.  It should be noted that all assays were performed in duplicate, and gene 
expression data was expressed using 2-∆CT method where ∆CT = (gene of interest – avg 
B2M & 28S).  Coefficient of variation for values between duplicates were less than 5% 
for all GOI’s and HKG’s. 
 
Protein immunoblotting 
Briefly, a third section of muscle from each time point per participant was 
weighed (~25 mg) and homogenized on ice with 300 μl of cell lysis homogenizing buffer 
[150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 20 mM Tris HCl, pH 7.5 
spiked with a protease inhibitor cocktail (Sigma, St. Louis, MO)].  Prior to SDS-PAGE, 
protein concentrations of cell lysis homogenates were determined spectrophotometrically 
using Bradford reagent (Bio-Rad Laboratories) with BSA being used as a standard curve.  
Following protein concentration determinations for each sample, a total of 30 μg of 
protein was diluted in Laemmli sample loading buffer spiked with 5% 2-
mercaptoethanol, heated at 95 C for 5 minutes, and loaded on handmade 12% 
polyacrylamide minigels (Bio-Rad Laboratories) for SDS-PAGE.  Each run lasted 75 
minutes at 150 V until the bromophenol blue tracer dye from the Laemmli buffer 




eluted from the gels onto nitrocellulose membranes using a “wet transfer” in an 
electrotransfer blotting apparatus (Bio-Rad Laboratories) with Towbin electrotransfer 
buffer.   Electrotransfers lasted 1 hour in duration at 100 V/380-500 mA.  Following 
electrotransfers, loading efficiencies were determined by staining nitrocellulose 
membranes with Ponceau S stain (Sigma, St. Louis, MO), membranes were destained in 
Tris-buffered saline spiked with 1% Tween-20 (TBST), and stored at 4 C overnight in 
TBST spiked with 5% nonfat blocking agent (NFBA) until immunoprobing experiments 
were performed.  The lack of consistent muscle [c-met] and [IGF-1] signals during pilot 
Western blotting experiments obviated the need to: 1) immunoprobe c-met using slot-
blotting methods whereby protein aliquots were loaded directly onto nitrocellulose 
membranes and probed as described below, and 2) detect muscle [IGF-1] using 
commercial enzyme immunoassay (EIA) methods.  For muscle [c-met] it should be noted 
that the secondary antibody solution was confirmed to yield no chemiluminescent signal 
and that the signal from the slot-blots were generated from primary antibody binding to 
the target antigen. 
Immunoblotting was carried out using mouse monoclonal antibodies against 
muscle-specific c-met (1:2,000-fold dilution; Cell Signaling Technology Inc., Manvers, 
MA) and PCNA (1:2,000-fold dilution; Cell Signaling Technology Inc.).  
Immunodetection of muscle [IGF-1] was performed using competitive EIA kits (DRG 
International, Mountainside, NJ).  For muscle [c-met], nonspecific binding sites on the 
nitrocellulose membranes were blocked with NFBA for 50 minutes at room temperature.  
Membranes were then incubated with one of the aforementioned primary antibody 




met slot blots, membranes were incubated with the primary antibody solution at 4 C 
overnight in order to increase antigen binding.  The primary antibody solution was then 
decanted, membranes were washed two times at 5 minutes per wash with TBST, and 
membranes were incubated with a horseradish peroxidase (HRP)-conjugated goat anti-
mouse antibody solution (20,000-fold dilution in TBST; Bio-Rad Laboratories) for 45 
minutes.  Finally, the secondary antibody solution was decanted, membranes were 
washed three times at 5 minutes per wash with TBST, and membranes were incubated 
with a an enhanced chemiluminescent reagent (Bio-Rad Laboratories) for 5 minutes.  
Membranes were then placed in the gel documentation system (Bio-Rad Laboratories), 
and immunoprobed band densities were determined using band densitometry using 
Quantity One software (Bio-Rad Laboratories).  The exposure times for each antigen 
were as follows: 2 minutes for PCNA Western blots and 2 minutes for c-met slot-blots.  
For c-met slot blots, membranes were initially probed with primary antibody, stripped in 
Western blotting stripping buffer for 5 minutes, and reprobed with the 2’ antibody 
solution only in order to ensure that there was not a false signal generated by non-specific 
binding of the secondary antibody solution.  All muscle [PCNA] and [c-met] data were 
expressed as band density/Ponceau density.  Muscle [IGF-1] was expressed as ng IGF-
1/mg protein.  Coefficient of variation values between duplicates were: PCNA = 10.4%, 
c-met = 8.8%, IGF-1 = 1.7%. 
 
Statistical analyses 
Due to the large variances commonly attributed with molecular variables (i.e., 
inter-individual differences in DNA, mRNA, and protein concentrations), the Shapiro-




normality in distribution existed.  For normally distributed molecular data, a two-way 
[age (young vs old males) x testing session (T1 biopsy, pre-T2 biopsy, pre-T3 biopsy, T4 
biopsy)] ANOVA with repeated measures was used to determine main and interactive 
effects.  Further, selected data that are normally distributed was correlated using the 
Pearson’s product-moment correlation.  For dependent variables that exhibited a non-
normal distribution (i.e., skewness and/or kurtosis > 2.0, or Shapiro-Wilk statistic p < 
0.05) then non-parametric statistics were performed.  Specifically, the Mann-Whitney U 
statistic was used to determine which condition(s) were significantly different at each 
time point for each non-normally distributed dependent variable (synonymous to an 
independent t-test).  The Friedman test was used to detect changes in non-normally 
distributed data amongst all conditions over time (i.e., detect a main effect for time 
amongst all groups).  If the Friedman statistic p-value is < 0.05 then Wilcoxin signed 
rank tests were employed as a post hoc measure to determine which time points were 
significantly different within both age groups (via the split file function).  Finally, 
selected variables that are non-normally distributed were correlated using the Spearman’s 
rank correlation.  An alpha of p ≤ 0.05 was used to determine significance for all 












Participant Demographics, Dietary Intakes, and Lifting Comparisons 
 Ten healthy younger males [means ± SE; age: 21.0 ± 0.5 years, body mass: 82.3 ± 
4.2 kg, height: 178.4 ± 2.2 cm, body fat percentage (3-site SKF: chest, abdomen, thigh): 
15.4 ± 2.9%] and ten healthy older males [age: 66.4 ± 1.6 years, body mass: 94.2 ± 3.7 
kg, height: 180.9 ± 2.2 cm, body fat percentage (3-site SKF: chest, abdomen, thigh): 27.4 
± 1.8%] volunteered to participate in this study.  According to 2-3 day food logs, caloric 
intake (young = 33.4 ± 5.1 kcal/kg/d, old = 19.5 ± 1.9 kcal/kg/d; p = 0.038), protein 
intake (young = 1.6 ± 0.2 g/kg/d, old = 0.8 ± 0.1 g/kg/d; p = 0.030), carbohydrate intake 
(young = 4.1 ± 0.6 g/kg/d, old = 2.3 ± 0.3 g/kg/d; p = 0.017), and fat intake (young = 1.2 
± 0.2 g/kg/d, old = 0.6 ± 0.1 g/kg/d; p = 0.006) were all greater in the young versus old 
males.  Between-age strength comparisons using independent samples t-tests indicated 
that the younger participants exhibited greater 1RMs for hack squat (young: 170.0 ± 10.9 
kg, old: 105.8 ± 10.4 kg; p = 0.001), leg press (young: 271.1 ± 14.6 kg, old: 182.7 ± 14.9 
kg; p < 0.001), leg extension (young: 64.8 ± 4.0 kg, old: 46.7 ± 2.8 kg; p = 0.002), as well 
as the cumulative training volume for the T1-T3 workouts (young: 36,392 ± 1,894 kg, 
old: 23,724 ± 1,639 kg; p < 0.001). 
 
Normality Distribution of Dependent Variables 
 As mentioned, the Shapiro-Wilk statistic was performed for each dependent 
variable at each time point to ensure a normality in distribution existed (Table 3).  




mRNA expression values were normally distributed across all time points and were 
analyzed using parametric statistics.  The other dependent variables including muscle 
[total protein], muscle [myofibrillar protein], MGF mRNA expression, CDK2/4 mRNA 
expression, CYCLIN D1 mRNA expression, IGF-1EA mRNA expression, MGF:IGF-1EA 
mRNA, MHCEMB mRNA expression, and MYOD mRNA expression values were 
analyzed using non-parametric statistics. 
 
Muscle [DNA] 
 Muscle [DNA] values are presented in Figure 7.  For the young group, muscle 
[DNA] values (ng/mg wet muscle) expressed as mean ± SE were: T1 = 346 ± 39, T2 = 
283 ± 37, T3 = 267 ± 44, T4 = 285 ± 27.  For the old group, muscle [DNA] values 
(ng/mg wet muscle) expressed as mean ± SE were: T1 = 336 ± 57, T2 = 318 ± 82, T3 = 
274 ± 30, T4 = 289 ± 33.  A mixed factorial (2 age groups x 4 time point) ANOVA 
indicated that there was no main group effect (p = 0.88), no main time effect (p = 0.07), 
and/or no age x time point interaction (p = 0.78). 
 
Muscle [Total Protein] and [Myofibrillar Protein] 
 Muscle [total protein] values are presented in Figure 8.  For the young group, 
muscle [total protein] values (μg/mg wet muscle) expressed as mean ± SE were: T1 = 81 
± 11, T2 = 87 ± 11, T3 = 91 ± 9, T4 = 84 ± 7.  For the old group, [total protein] values 
(μg/mg wet muscle) expressed as mean ± SE were: T1 = 75 ± 5, T2 = 87 ± 12, T3 = 68 ± 
5, T4 = 79 ± 10.  Between-group mean comparisons at each time point using separate 




between age groups (p-values: T1 = 0.97, T2 = 0.91, T3 = 0.11, T4 = 0.53).  A Friedman 
test indicated that there was no main effect for time regarding muscle [total protein] 
values (p = 0.58). 
Muscle [myofibrillar protein] values are presented in Figure 9.  For the young 
group, muscle [myofibrillar protein] values (μg/mg wet muscle) expressed as mean ± SE 
were: T1 = 16 ± 2, T2 = 14 ± 1, T3 = 12 ± 1, T4 = 13 ± 1.  For the old group, 
[myofibrillar protein] values (μg/mg wet muscle) expressed as mean ± SE were: T1 = 14 
± 1, T2 = 13 ± 1, T3 = 12 ± 1, T4 = 13 ± 1.  Between-group mean comparisons at each 
time point using separate Mann Whitney U tests indicated that muscle [total protein] 
values were not different between age groups (p-values: T1 = 0.55, T2 = 0.91, T3 = 0.39, 
T4 = 0.74).  A Friedman test indicated that there was no main effect for time regarding 
muscle [myofibrillar protein] values (p = 0.14). 
 
Muscle [Total RNA] 
Muscle [total RNA] values are presented in Figure 10.  For the young group, 
muscle [total RNA] values (ng/mg wet muscle) expressed as mean ± SE were: T1 = 379 
± 28, T2 = 328 ± 27, T3 = 427 ± 38, T4 = 342 ± 35.  For the old group, muscle [total 
RNA] values (ng/mg wet muscle) expressed as mean ± SE were: T1 = 387 ± 30, T2 = 
333 ± 34, T3 = 434 ± 46, T4 = 332 ± 49.  A mixed factorial (2 age groups x 4 time point) 
ANOVA indicated that there was no main group effect (p = 0.99) nor was there an age x 
time point interaction (p = 0.78), although there was a main time effect (p = 0.002).  As a 
follow-up analysis to the significant main time effect, within-group dependent t-tests 




0.010) groups from T3 to T4.  Conversely, there was also a significant decrease in muscle 
[total RNA] within the old group (p = 0.021) groups from T3 to T4.  There were no other 
within-group changes in muscle [total RNA] over the course of the exercise intervention. 
 
Pre- and Post-Exercise Expression of Genes of Interest 
CDK2 mRNA expression values are presented in Figure 12.  For the young group, 
CDK2 mRNA expression values (relative to B2M & 28S avg) expressed as mean ± SE 
were: T1 = 0.00015965 ± 0.00003109, T2 = 0.00021074 ± 0.00004638, T3 = 0.00023999 
± 0.00007926, T4 = 0.00016971 ± 0.00003644.  For the old group, CDK2 mRNA 
expression values (relative to B2M & 28S avg) expressed as mean ± SE were: T1 = 
0.00035216 ± 0.00015678, T2 = 0.00021124 ± 0.00004691, T3 = 0.00019293 ± 
0.00003765, T4 = 0.00026626 ± 0.00007150.  Between-group mean comparisons at each 
time point using separate Mann Whitney U tests indicated that CDK2 mRNA expression 
values were not different between age groups (p-values: T1 = 0.60, T2 = 1.00, T3 = 0.97, 
T4 = 0.32).  A Friedman test indicated that there was no main time effect regarding 
CDK2 mRNA expression values (p = 0.71). 
CDK4 mRNA expression values are presented in Figure 13.  For the young group, 
CDK4 mRNA expression values (relative to B2M & 28S avg) expressed as mean ± SE 
were: T1 = 0.00017246 ± 0.00002463, T2 = 0.00020397 ± 0.00003755, T3 = 0.00014755 
± 0.00002140, T4 = 0.00019044 ± 0.00003366.  For the old group, CDK4 mRNA 
expression values (relative to B2M & 28S avg) expressed as mean ± SE were: T1 = 
0.00017843 ± 0.00004542, T2 = 0.00014986 ± 0.00002405, T3 = 0.00017713 ± 
0.00005429, T4 = 0.00018076 ± 0.00004162.  Between-group mean comparisons at each 




values were not different between age groups (p-values: T1 = 0.80, T2 = 0.39, T3 = 0.85, 
T4 = 0.63).  A Friedman test indicated that there was no main time effect regarding 
CDK4 mRNA expression values (p = 0.60). 
CYCLIN D1 mRNA expression values are presented in Figure 14.  For the young 
group, CYCLIN D1 mRNA expression values (relative to B2M & 28S avg) expressed as 
mean ± SE were: T1 = 0.00002007 ± 0.00000505, T2 = 0.00003026 ± 0.00001091, T3 = 
0.00004011 ± 0.00001927, T4 = 0.00002659 ± 0.00000871.  For the old group, CYCLIN 
D1 mRNA expression values (relative to B2M & 28S avg) expressed as mean ± SE were: 
T1 = 0.00006085 ± 0.00001868, T2 = 0.00006297 ± 0.00000899, T3 = 0.00007353 ± 
0.00002029, T4 = 0.00005950 ± 0.00001850.  Between-group mean comparisons at each 
time point using separate Mann Whitney U tests indicated that CYCLIN D1 mRNA 
expression values were significantly greater at T1 (p = 0.017) and T2 (p = 0.017) and 
tended to be greater at T3 (p = 0.063) and T4 (0.052) older versus younger participants.  
A Friedman test indicated that there was no main time effect regarding CYCLIN D1 
mRNA expression values (p = 0.56). 
IGF-1EA mRNA expression values are presented in Figure 15.  For the young 
group, IGF-1EA  mRNA expression values (relative to B2M & 28S avg) expressed as 
mean ± SE were: T1 = 0.00047902 ± 0.0000887, T2 = 0.00056631 ± 0.00004675, T3 = 
0.00057156 ± 0.00010560, T4 = 0.00055007 ± 0.00011956.  For the old group, IGF-1EA  
mRNA expression values (relative to B2M & 28S avg) expressed as mean ± SE were: T1 
= 0.00044641 ± 0.00004274, T2 = 0.00064208 ± 0.00011577, T3 = 0.00059338 ± 
0.00008754, T4 = 0.00058086 ± 0.00015185.  Between-group mean comparisons at each 




expression values were not different between age groups (p-values: T1 = 0.68, T2 = 0.97, 
T3 = 0.50, T4 = 0.97).  A Friedman test indicated that there was no main time effect 
regarding muscle IGF-1EA mRNA expression values (p = 0.076). 
MGF mRNA expression values are presented in Figure 11.  For the young group, 
MGF mRNA expression values (relative to B2M & 28S avg) expressed as mean ± SE 
were: T1 = 0.00000337 ± 0.00000132, T2 = 0.00000474 ± 0.00000083, T3 = 0.00000562 
± 0.00000156, T4 = 0.00000577 ± 0.00000168.  For the old group, MGF mRNA 
expression values (relative to B2M & 28S avg) expressed as mean ± SE were: T1 = 
0.00000218 ± 0.00000038, T2 = 0.00000495 ± 0.00000106, T3 = 0.00000498 ± 
0.00000119, T4 = 0.00000687 ± 0.00000209.  Between-group mean comparisons at each 
time point using separate Mann Whitney U tests indicated that MGF mRNA expression 
values were not different between age groups (p-values: T1 = 0.91, T2 = 0.91, T3 = 0.97, 
T4 = 0.74).  A Friedman test indicated that there was a main time effect regarding muscle 
MGF mRNA expression values (p = 0.017).  As a follow-up analysis to the significant 
main time effect, within-group Wilcoxin signed rank tests indicated that MGF mRNA 
expression increased at T2 (p = 0.047), T3 (p = 0.037), and T4 (p = 0.022) compared to 
T1 within the old group.  There were no within-group changes from baseline values in 
MGF mRNA expression within the young group throughout the duration of the exercise 
intervention (p > 0.05). 
MGF:IGF-1EA mRNA expression values are presented in Figure 16.  For the 
young group, MGF:IGF-1EA  mRNA expression values expressed as mean ± SE were: 
T1 = 0.0059133 ± 0.0011131, T2 = 0.0085498 ± 0.0009540, T3 = 0.0099931 ± 




expression values expressed as mean ± SE were: T1 = 0.0049602 ± 0.0008362, T2 = 
0.0075066 ± 0.0011970, T3 = 0.0075284 ± 0.0010465, T4 = 0.0109819 ± 0.0012423.  
Between-group mean comparisons at each time point using separate Mann Whitney U 
tests indicated that MGF:IGF-1EA  mRNA expression values were not different between 
age groups (p-values: T1 = 0.74, T2 = 0.55, T3 = 0.40, T4 = 0.80).  A Friedman test 
indicated that there was a main time effect regarding muscle MGF:IGF-1EA mRNA 
expression values (p = 0.003).  As a follow-up analysis to the significant main time 
effect, within-group Wilcoxin signed rank tests indicated that MGF:IGF-1EA mRNA 
expression increased at T3 (p = 0.028), and T4 (p = 0.005) compared to T1 in the old 
group.  There were no within-group changes from baseline values in MGF:IGF-1EA 
mRNA expression within the young group throughout the duration of the exercise 
intervention (p > 0.05). 
MHCEMB mRNA expression values are presented in Figure 17.  For the young 
group, MHCEMB  mRNA expression values expressed as mean ± SE were: T1 = 
0.00006773 ± 0.00001301, T2 = 0.00026983 ± 0.00010801, T3 = 0.00008849 ± 
0.00002592, T4 = 0.00011329 ± 0.00002316.  For the old group, MHCEMB mRNA 
expression values expressed as mean ± SE were: T1 = 0.00008484 ± 0.00003740, T2 = 
0.00011562 ± 0.00002667, T3 = 0.00045068 ± 0.00021586, T4 = 0.00022454 ± 
0.00008955.  Between-group mean comparisons at each time point using separate Mann 
Whitney U tests indicated that MHCEMB  mRNA expression values were not different 
between age groups (p-values: T1 = 0.50, T2 = 0.53, T3 = 0.28, T4 = 0.97).  A Friedman 
test indicated that there was a main time effect regarding muscle MHCEMB mRNA 




effect, within-group Wilcoxin signed rank tests indicated that MHCEMB mRNA 
expression increased at T4 (p = 0.011) compared to T1 in the young group.  There were 
no within-group changes from baseline values in MHCEMB mRNA expression within the 
old group throughout the duration of the exercise intervention (p > 0.05). 
MYOD mRNA expression values are presented in Figure 18.  For the young 
group, MYOD mRNA expression values expressed as mean ± SE were: T1 = 0.00015993 
± 0.00002750, T2 = 0.00022781 ± 0.00002890, T3 = 0.00021403 ± 0.00005122, T4 = 
0.00016172 ± 0.00002386.  For the old group, MYOD mRNA expression values 
expressed as mean ± SE were: T1 = 0.00022134 ± 0.00003507, T2 = 0.00028401 ± 
0.00006474, T3 = 0.00021536 ± 0.00004405, T4 = 0.00018959 ± 0.00006055.  Between-
group mean comparisons at each time point using separate Mann Whitney U tests 
indicated that MYOD mRNA expression values were not different between age groups (p-
values: T1 = 0.19, T2 = 0.85, T3 = 0.80, T4 = 0.53).  A Friedman test indicated that there 
was a main time effect regarding muscle MYOD mRNA expression values (p = 0.006).  
As a follow-up analysis to the significant main time effect, within-group Wilcoxin signed 
rank tests indicated that MYOD mRNA expression increased at T2 (p = 0.013) compared 
to T1 in the young group.  There were no within-group changes from baseline values in 
MYOD mRNA expression within the old group throughout the duration of the exercise 
intervention (p > 0.05). 
P21CIP1 mRNA expression values are presented in Figure 19.  For the young 
group, P21CIP1 mRNA expression values expressed as mean ± SE were: T1 = 0.00038837 
± 0.00016837, T2 = 0.00022784 ± 0.00004659, T3 = 0.00025679 ± 0.00003385, T4 = 




expressed as mean ± SE were: T1 = 0.00033576 ± 0.00012319, T2 = 0.00035345 ± 
0.00005194, T3 = 0.00031180 ± 0.00005617, T4 = 0.00023953 ± 0.00002607.  A two-
way (age x session) ANOVA employing the Huynh-Feldt indicated that there was no 
time effect (p = 0.13), group effect (p = 0.42), or interaction effect (p = 0.37) for P21CIP1 
mRNA expression values.  
P27KIP1 mRNA expression values are presented in Figure 20.  For the young 
group, P27KIP1 mRNA expression values (relative to B2M & 28S avg) expressed as mean 
± SE were: T1 = 0.00074520 ± 0.00009994, T2 = 0.00088720 ± 0.00011419, T3 = 
0.00075993 ± 0.00013020, T4 = 0.00077444 ± 0.00011908.  For the old group, P27KIP1 
mRNA expression values (relative to B2M & 28S avg) expressed as mean ± SE were: T1 
= 0.00100762 ± 0.00018271, T2 = 0.00087315 ± 0.00016167, T3 = 0.00081495 ± 
0.00015854, T4 = 0.00064139 ± 0.00014644.  A two-way (age x session) ANOVA 
indicated that there was no time effect (p = 0.28), group effect (p = 0.79), or interaction 
effect (p = 0.28) for P27KIP1 mRNA expression values. 
 
 
Muscle [PCNA], [c-met] and [IGF-1] 
Muscle [PCNA] values are presented in Figure 21.  For the young group, muscle 
[PCNA] expressed in arbitrary density units (ADUs) as mean ± SE were: T1 = 0.020 ± 
0.007, T2 = 0.027 ± 0.008, T3 = 0.024 ± 0.007, T4 = 0.024 ± 0.007.  For the old group, 
muscle [PCNA] expressed in ADUs as expressed as mean ± SE were: T1 = 0.018 ± 
0.006, T2 = 0.019 ± 0.005, T3 = 0.019 ± 0.005, T4 = 0.019 ± 0.005.  Between-group 
mean comparisons at each time point using separate Mann Whitney U tests indicated that 




0.85, T3 = 0.85, T4 = 0.97).  A Friedman test indicated that there was not a main time 
effect regarding muscle [PCNA] values (p = 0.44).  
Muscle [c-met] values are presented in Figure 22.  For the young group, muscle 
[PCNA] expressed in arbitrary density units (ADUs) as mean ± SE were: T1 = 1.17 ± 
0.12, T2 = 1.42 ± 0.14, T3 = 0.90 ± 0.13, T4 = 0.72 ± 0.06.  For the old group, muscle [c-
met] expressed in ADUs as expressed as mean ± SE were: T1 = 1.01 ± 0.21, T2 = 1.23 ± 
0.13, T3 = 1.05 ± 0.11, T4 = 0.97 ± 0.12.  Between-group mean comparisons at each time 
point using separate Mann Whitney U tests indicated that muscle [c-met] values were not 
different between age groups (p-values: T1 = 0.14, T2 = 0.48, T3 = 0.48, T4 = 0.11).  A 
Friedman test indicated that there was a main time effect regarding muscle [c-met] values 
(p < 0.001).   As a follow-up analysis to the significant main time effect, within-group 
Wilcoxin signed rank tests indicated that muscle [c-met] values increased at T2 (p = 
0.005) and decreased at T4 (p = 0.022) compared to T1 in the young group.  There were 
no within-group changes from baseline values in muscle [c-met] values within the old 
group throughout the duration of the exercise intervention (p > 0.05). 
Muscle [IGF-1] values are presented in Figure 23.  For the young group, muscle 
[IGF-1] expressed in ng/mg skeletal muscle as mean ± SE were: T1 = 0.195 ± 0.153, T2 
= 0.058 ± 0.022, T3 = 0.215 ± 0.173, T4 = 0.166 ± 0.112.  For the old group, muscle 
[IGF-1] expressed in ng/mg skeletal muscle as mean ± SE were: T1 = 0.219 ± 0.159, T2 
= 0.158 ± 0.120, T3 = 0.234 ± 0.196, T4 = 0.439 ± 0.245.  Between-group mean 
comparisons at each time point using separate Mann Whitney U tests indicated that 




0.58, T3 = 0.53, T4 = 0.63).  A Friedman test indicated that there was no main time effect 








Mechanistic studies such as the current investigation are of critical importance 
due to the fact that the hypertrophic potential to resistance exercise has been shown to be 
unexplainably impaired with aging [9, 15, 121], albeit other evidence suggests that 
resistance exercise-induced muscle hypertrophy is similar between younger and older 
adults [122].  In this regard, studies such as the current investigation allow scientists to 
better understand the etiology behind muscle aging.  This study specifically outlined the 
age-related differences in the expression of genes and proteins related to satellite cell 
activity prior to and following three conventional bouts of resistance exercise.  Given that 
past research has indicated that: 1) the satellite cell proliferative potential is impaired in 
older versus younger males at rest [3] and in response to weeks of resistance exercise 
[15], and 2) satellite cell proliferation impairments are causally linked to long-term 
increases in muscle mass [14], our laboratory was interested in determining if age-related 
impairments in myogenic genes and/or growth factors existed prior to and during one 
week of resistance training.  In the current study, three sequential bouts of conventional 
lower body resistance training increased muscle [c-met], a protein marker indicative of 
satellite cell quantity, in young males 48 hours following the first bout (p < 0.01) and 
decreased this marker in young males 24 hours following the third bout (p < 0.05), 
whereas this value did not change within the old group.  Likewise, MYOD gene 
expression modestly increased 48 hours following the first bout (p < 0.05) and MHCEMB 
gene expression modestly increased 24 hours following the third bout (p < 0.05) relative 




expression increased at T2-4 in the older group relative to baseline values (p < 0.05) 
which is contrary to other reports examining this gene at different biopsy time points.  
Taking all of these findings into consideration indicate that repeated training bouts: 1) 
may increase satellite cell number in younger males following the first initial bout as 
evidenced with the current muscle [c-met] data, 2) do not alter the expression of genes 
indicative of satellite cell activity (i.e., CDK2, CDK4, CYCLIN D1, MYOD, P21CIP1, 
P27KIP1) and/or the expression of IGF-1EA up to 24-48 hours following exercise in 
younger or older males, 3) do not increase other markers of satellite cell proliferation 
(i.e., muscle [PCNA], and [DNA]) in either age group at the sampled time points, and 4) 
do not alter [myofibrillar protein] or [total protein] in either age group at the sampled 
time points.  In regards to the pre-intervention findings, CYCLIN D1 mRNA was more 
highly expressed in older versus younger males (p < 0.05), whereas all other genes and 
markers of satellite cell activity were similar between age groups.  Therefore, these data 
may also suggest that the proliferative potential of satellite cells is sustained during 
resting, un-exercised states in aging males.  Note that 3-day food logs revealed that 
caloric and macronutrient intakes relative to body mass were also found to be greater in 
the young versus old group.  Interestingly, researchers that have reduced protein intakes 
(i.e., 0.5 g/kg/d) over a one-week period in 50-80 year-old males demonstrated that 
inadequate Calorie and/or protein intake adversely affects the skeletal muscle 
transcriptome [123].  These authors stated: 
“The results of this study show that older persons who consume inadequate 
dietary protein for 1 wk experience a wide variety of changes in transcript levels 




and physiologic changes that may precede accommodation, including 
inflammatory stress, reduced metabolism and oxygen transport, reduced protein 
synthesis, and muscle wasting.” 
Nonetheless, our current method of dietary assessment using 3-day recalls contains 
methodological limitations (i.e., under-reporting which is common with these methods as 
well as a limited n-size) and precludes us from making inferences as to how dietary 
variables may affect the skeletal muscle environment in the current study. 
 
Baseline Markers of Satellite Cell Activity between Age Groups 
As mentioned, CYCLIN D1 gene expression was significantly greater in older 
versus younger males (p < 0.05), whereas all other genes (i.e., CDK2, CDK4, MHCEMB, 
MYOD, P27KIP1, P21CIP1) and markers of satellite cell activity (i.e., muscle [DNA], 
muscle [PCNA], and muscle [c-met]) were similar between age groups.   Contrary to the 
initial hypotheses, these data seemingly suggest that the proliferative states of satellite 
cells are sustained during resting, un-exercised states in aging males versus younger 
counterparts.  This contention, however, possesses methodologically limitations due to 
the fact that fiber type-specific satellite cell numbers were not microscopically examined.  
In this regard, Verdijk et al. [3] used immunohistochemistry to double-label adjacent 
muscle biopsy cross sections and determined that the number of type II fiber satellite 
cells were approximately 50% lower in 76 year old versus 20 year old males.  However, 
other researchers have determined that satellite cell number in the human vastus lateralis 
muscle does not change with aging [15, 16, 118, 124].  Assuming that satellite cells 




quantified from the lysate of a large, representative muscle sample in the current study 
provides evidence to suggest that satellite cell numbers are indeed similar between 
younger and older males.  In order to support this finding, future attempts will be made 
by our laboratory to quantify satellite cell numbers in these participants using 
immunohistochemistry. 
 The finding that most of the investigated cell cycle-regulating genes (i.e., CDK2, 
CDK4, MYOD, P21CIP1, and P27KIP1) were similar between younger and older 
participants is in agreement with some investigations and dissimilar with others.  For 
instance, the intramuscular protein expression of cyclin D1 and p27Kip1 have not been 
affected by human aging [18].  Conversely, Raue et al. [91] reported that the myogenic 
expression of MYOD mRNA is 58% greater in older versus younger women.  Recent 
rodent data has demonstrated a 50% decrement in p27Kip1 protein levels from older 
cultured rat satellite cells [19], and similar data has reported a decrement in the genetic 
expression of P57KIP2 and P21CIP1 from the skeletal muscle of aged mice; an effect which 
may contribute to a diminished capability of satellite cells to differentiate [30].  One 
explanation for the divergent findings between the current and aforementioned studies is 
due to the fact that baseline gene expression was normalized to the arithmetic average of 
two housekeeping genes which have been shown to not be affected by aging.  In this 
regard, Raue et al. normalized the reported MYOD data to GAPDH, which we have found 
to be expressed more highly (+100%) in younger participants.  Therefore, normalizing 
MYOD mRNA expression values to GAPDH, which decreases with aging, will greatly 
inflate these data in older participants.  The increased mRNA expression of CYCLIN D1 




skeletal muscle are attempting to sustain proliferative capabilities.  In support of this 
hypothesis, a five-week heterochronic parabiosis experiment (or the pairing of the 
circulatory systems of young and old animals) followed by muscle injury demonstrated 
that the old muscle from heterochronic pairing exhibited a substantially greater number of 
MHCEMB-positive cells (indicative of satellite cell proliferation and differentiation) 
compared to the older muscles in isochronic pairings [107].  In their concluding remarks, 
Conboy et al. stated, 
Together, these in vivo and in vitro data demonstrate that components in young 
serum alone are capable of reversing the molecular and cellular aspects of age-
related decline in muscle stem cell activation.  In addition, it also seems that 
factors in old serum negatively affect the processes required for satellite cell 
activation and muscle repair. 
Contextually applying these data to the current study may indicate that the endocrine 
and/or paracrine environments in older humans quells satellite cell activity; an effect 
which obviates the need for an increased expression of proliferative genes (such as 
CYCLIN D1) in order to maintain satellite cell populations. 
 
Baseline MGF and IGF-1EA Gene and IGF-1 Protein Expression between Age Groups 
 The current data demonstrate that MGF and IGF-1EA mRNA expression patterns 
remain stable with aging in resting, unexercised states which is in partial or full 
agreement with numerous investigations.  Haddad and Adams [22] recently determined 
that resting MGF mRNA expression was similar between young and old rodents, albeit 




findings are in agreement with Hameed et al. [10] as well as Petrella et al. [15] who 
determined that MGF and IGF-1EA mRNA is similarly expressed in the skeletal muscle 
of young and old humans.   
 Muscle [IGF-1] peptide concentrations also remain stable with aging in resting, 
unexercised states which, to our knowledge, is a novel finding in humans.  Haddad and 
Adams [22] recently demonstrated that IGF-1 receptor concentrations are significantly 
greater in older versus younger rodents, albeit insulin receptor substrate-1 (IRS-1, both 
total and phosphorylated/activated levels) as well as phosphorylated Akt concentrations 
were depressed in older versus younger rodents.  Simply stated, our findings illustrate 
that: 1) IGF-1 peptide expression is minimally affected with aging and 2) a molecular 
disconnect between IGF-1receptor signaling in skeletal muscle (i.e., the IGF-1 receptor-
mediated activation of IRS-1) may be of further relevance in regards to the development 
of sarcopenia. 
 
Myogenic Gene Expression Patterns and Muscle [IGF-1] Following Resistance Exercise 
The lack of change in the current post-exercise CDK2, CDK4, CYCLIN D1, 
P21CIP1, and P27KIP1 mRNA expression data may be explained by the effects of 
resistance training on the transient (i.e., within 24 hours) versus the prolonged expression 
(i.e., 48 hours post-exercise) patterns.  For instance, a plethora of evidence exists 
suggesting that myogenic gene expression occurs transiently (i.e., within 24 hours) in 
response to mechanical loading.  Psilander et al. [57] demonstrated that MYOGENIN, 
MYOD, and MRF4 mRNA levels were elevated in human skeletal muscle by 100-400% 




repetitions.  Likewise, a significant 4-hour post-exercise increase in MYOD mRNA (2.0-
fold) has also been reported to occur in younger and older women [91], and a 12-24-hour 
post-exercise increase in MYOD mRNA (+83%), CYCLIN D1 mRNA (+50%), and 
P21CIP1 mRNA (+1,600%) has been reported to occur in younger males and females [29].  
Bamman et al. [17] also reported that P27KIP1 mRNA modestly decreased (-16%) and 
CYCLIN D1 mRNA modestly increased (+34%) in younger and older males and females 
24 hours following resistance exercise, and our laboratory has found that one bout of 
lower body resistance training increased CDK4 expression 6 hours post-exercise (+60%), 
decreased MYOD expression 6 hours post-exercise (-80%), decreased P27KIP1 expression 
6 hours post-exercise (-640%), and substantially increased P21CIP1 expression 2- and 6 
hours post-exercise (+1,250% and +4,670%, respectively) in younger males [125].  Thus, 
the mRNA expression patterns of CDK2, CDK4, CYCLIN D1, P21CIP1, and P27KIP1 are 
seemingly responsive to mechanical loading within a transient post-exercise window 
which was not captured in the current investigation.  Furthermore, three sequential bouts 
of conventional resistance exercise appear to have no summative effects on the 
culmination of these genes in younger or older males. 
As mentioned previously, MGF expression increased at T2 (+224%), T3 
(+174%), and T4 (+290%) in the older group relative to baseline values (p < 0.05), and 
IGF-IEA mRNA expression patterns remained unaltered in both age groups; both of these 
findings being contrary to other reports examining these genes at different biopsy time 
points.  Hameed et al. [10] determined that MGF mRNA expression substantially 
increased in younger (+2 – +864%) but not older subjects 2.5 hours following resistance 




in younger and older humans 24 hours following a single bout of conventional resistance 
exercise, albeit post hoc analysis revealed a significant increase in MGF after exercise in 
young men only (+91%).  Equivocal evidence exists demonstrating that resistance 
exercise did not affect MGF mRNA expression in younger subjects up to 48 hours 
following exercise, whereas IGF-1EA mRNA content decreased transiently following 
exercise (-44% at 1 and 6 h post-exercise, respectively) [57].  Thus, the current data is the 
first to suggest that: 1) the myogenic expression of MGF mRNA may be upregulated in a 
delayed fashion following conventional resistance exercise in older versus younger 
adults, 2) IGF-1EA mRNA expression is minimally affected 24-48 hours following three 
exercise bouts in younger and older humans, and 3) repeated bouts of resistance exercise 
may lead to the culmination in MGF mRNA in older humans.  If the latter findings hold 
true then there may be physiological ramifications of the delayed post-exercise MGF 
expression pattern in older skeletal muscle.  For instance, protein synthesis rates are 
known to transiently peak within a 24-hour window following resistance exercise [126].  
Hence, if the peak expression of MGF mRNA occurs when post-exercise protein 
synthesis rates return to baseline in older skeletal muscle, then MGF peptide translation 
may not occur at an appreciable level.  Therefore, future investigations need to discern if 
an increase in skeletal muscle MGF peptide content occurs in younger and older muscle 
following repeated training bouts and, more importantly, how potential increases in this 
peptide are crucial for long-term resistance training adaptations. 
 Contrary to the aforementioned findings, MYOD (+60%) and MHCEMB (+130%) 
mRNA expression significantly increased compared to baseline values in the younger 




aforementioned investigations have demonstrated that MYOD mRNA expression 
increases in humans in response to resistance training [29, 57, 91].  Furthermore, post-
exercise increases in the MyoD transcription factor have been shown to shadow increases 
in MYOD mRNA expression [93, 127].  The MyoD transcription factor is known to 
initiate myoblast differentiation as well as increase transcription of contractile, 
cytoskeletal and metabolic genes [127], albeit no study has demonstrated that 
differentiation occurs in response to one training session.  Thus, the increase in MYOD 
mRNA within the young group is somewhat of a ‘normal’ myogenic response to 
resistance exercise that may lead to the eventual differentiation of satellite cells once the 
need for extra myonuclear domains is warranted.  Conversely, the increase in MHCEMB 
transcripts within the young group 24 hours following the third exercise bout is a novel 
finding.  Our laboratory has previously determined that MHCEMB mRNA expression does 
not increase in younger or older males 24 hours following a single lower body exercise 
bout [113].  However, the increase observed in the current study within the young group 
following the third exercise bout may indicate that a subpopulation of satellite cells may 
have begun differentiating at this time point [31].  In this regard, future 
immunohistochemistry studies (i.e., identifying MHCEMB+ cells with fluorescently-
tagged antibodies) mimicking the current study design should be employed to confirm 
these findings. 
 Interestingly, our results are the first to demonstrate that repeated conventional 
exercise bouts do not alter total muscle IGF-1 peptide concentrations in younger or older 
human skeletal muscle.  This finding contradicts other data in the current investigation 




T4 (p = 0.022) compared to T1 within the old group.  Further, this data contradicts recent 
data demonstrating that muscle MGF and IGF-1Ea peptides significantly increased 
~125% 2 days and the IGF-1Ea peptide increase was sustained ~150% 5 days following 
an eccentric leg extensor bout [128].  Note, however, that we demonstrated that IGF-1 
peptides increased 28%, 464%, and 326% in the young group and 175%, 837%, and 
685% in the old group during T2-T4, albeit the large inter-individual responses over the 
training period precluded these changes from being significant.  Our findings are in 
statistically in agreement with O’Reilly et al. [55] who recently demonstrated that one 
bout of eccentric exercise did not alter muscle HGF peptide concentrations at 4 hours, 24 
hours, 72 hours or 120 hours post-exercise.  Interestingly, Haddad and Adams [22] 
similarly demonstrated that young rodents experienced an increase in IGF-1 receptor 
activation 24 hours following a simulated resistance exercise bout, whereas old rodents 
did not experience this phenomenon; with this increase in young rodents returning to 
baseline at 48 hours post-exercise.  This report seems to suggest that post-exercise IGF-1 
receptor ligation and potentially muscle IGF-1 peptide levels peak within a 24-hour 
window in mammals.  Taking all of these findings into consideration suggest that either: 
1) conventional resistance exercise transiently increases the autocrine expression of 
muscle IGF-1 peptides following exercise and the current investigation did not capture 
this response, or 2) repetitive conventional exercise bouts may be needed to increase the 
mRNA accumulation of IGF-1 mRNA variants which eventually leads to an increase in 
the anabolic IGF-1 peptide signal in the muscle bed.  In this regard, future research 
should examine how chronic resistance training affects muscle IGF-1 mRNA variants 




concert with the phenotypic adaptations that occur with chronic training.  These data will 
determine the relative importance of IGF-1 signaling with the process of skeletal muscle 
hypertrophy as well as how aging affects these processes. 
 
Muscle [DNA], [PCNA], and [c-met] Following Resistance Exercise 
There were no statistical differences within or between age groups for muscle 
[DNA] prior to or throughout the exercise intervention.  While the DNA quantification 
method has been used successfully in the past to track changes in DNA following 
impractical and extreme mechanical overloading protocols in rodents [60], the lack of 
statistical changes in muscle [DNA] throughout the conventional exercise intervention is 
likely due to the lack of assay sensitivity.  For example, it has been shown that satellite 
cell myonuclei contribute to approximately 2% of the total muscle myonuclear pool, and 
that these cells form 4-8 cell aggregates from a quiescent parent cell 3 days following a 
muscle-damaging stimulus [129].  Assuming the unlikely chance that 100% of the 
satellite cells in every subject proliferated into 8-cell clusters (or increase up to 800% in 
cell number) during the one-week training period would yield an approximate 14% 
increase in muscle [DNA].  In accordance with the muscle [c-met] values, satellite cell 
number likely modestly increased in younger males after one training bout, which has 
been reported previously to occur [55], and these increases were not consistently detected 
using fluorometric DNA quantification methods. 
Although muscle [c-met] increased in the young group at T2, muscle [PCNA] 
values remained unaltered in both age groups throughout the one-week intervention.  




leading strand synthesis during DNA replication.  Furthermore, in vitro work has 
determined that PCNA concentrations increase prior increases in cell number during 
satellite cell proliferation [69].  The lack of change in PCNA indicated that either: 1) the 
biopsying time points did not capture changes in PCNA when/if they occurred in the 
young group between T1 and T2, and/or 2) muscle PCNA did not change because 
satellite cell proliferation did not occur at other time points.  This is a novel finding due 
to the fact that muscle PCNA protein expression is rarely examined in vivo settings.  One 
recent study did examine the expression of muscle PCNA protein between healthy and 
liver-diseased rodents and reported that muscle [PCNA] was significantly lower in the 
latter group [130].  In lieu of their findings these authors stated, “In the present study, 
lower PCNA levels in the gastrocnemius muscle of [diseased] rats suggest impaired 
function of satellite cells.”  Interestingly, Deldicque et al. [131] recently reported that 
PCNA mRNA significantly increased immediately and 72 hours following 10 sets of 10 
leg extensor repetitions at 80% 1RM in young males, while returning to baseline levels 
24 hours post-exercise.  Therefore, if PCNA protein values also follow the 
abovementioned trend then it is likely that the biopsy time points in the current study did 
not capture PCNA protein responses to exercise. 
As previously mentioned, muscle [c-met] initially increased at T2 and decreased 
below baseline values by T4 in the young group only.  The former finding is in 
agreement with numerous investigations demonstrating that one bout of eccentric 
resistance exercise is capable of significantly increasing satellite cell number in young 
males one to five days following exercise [16, 55, 65].  Thus, while these findings need to 




resistance exercise is capable of stimulating increases in satellite cell number in young 
males.  The inability for muscle [c-met] to increase in the older participants at any point 
throughout the intervention is also in agreement with a previous study that demonstrated 
that satellite cell proliferation is quelled in older individuals 24 hours following a 
strenuous eccentric exercise bout [16]; specifically, young males exhibited a 141% 
increase in satellite cell number and old men exhibited a 51% increase.  Therefore, due to 
the fact that conventional resistance exercise is not as damaging as eccentric exercise, the 
three sequential exercise bouts employed in the current study was not enough of a 
mechanical stimulus to activate satellite cells in older individuals. 
The decrement in muscle [c-met] within the young group at T4 is more difficult to 
explain, albeit it does seem to follow a similar physiological pattern which has been 
reported by previous investigations examining satellite cell number following acute 
versus prolonged resistance training.  For instance, acute resistance training bouts have 
been shown to increase satellite cell number (+150-200% [16, 55, 65]) much greater than 
prolonged training programs spanning 12-16 weeks (i.e., +46% [39] and +49% [15]) in 
young males.  What is more compelling is data reported by O’Reilly et al. [55] 
demonstrating that satellite cell numbers peaked three days following a strenuous 
exercise bout in young men, and began returning back to baseline values 5 days post-
exercise.  Taking all of these data into consideration may suggest that satellite cell 
proliferation creates satellite cell numbers that exceed physiological needs following an 
initial exercise bout.  Furthermore, a subpopulation of these ‘unneeded’ satellite cells 
may undergo apoptosis during more prolonged post-exercise time points bringing satellite 




hypothesis since no one has ever examined potential apoptotic activity in skeletal muscle 
in concert with microscopically examining satellite cell numbers during prolonged 
recovery periods following resistance exercise. 
 
Conclusions 
In summary, these data suggest that: 1) three consecutive bouts of resistance 
exercise seem to significantly increase a marker indicative of satellite cell quantity 
concomitant with the increased expression of a select few myogenic genes in younger 
participants only (i.e., MYOD at T2 and MHCEMB at T4), 2) repeated exercise bouts 
facilitated a summation effect on MGF expression only in older individuals which is 
contrary to preliminary research examining this gene in these populations, and 3) both 
age groups retain proliferative capabilities during resting, unexercised states given the 
similarities between these groups in regards to muscle [PCNA], muscle [c-met], CDK2, 
CDK4, as well as an increased CYCLIN D1 mRNA expression in older individuals.  
Taking all of these findings into consideration suggests that additional exercise bouts may 
be needed to stimulate satellite cell activity during the initial stages of resistance training 
in older populations, albeit future research should employ immunohistochemistry in order 
to confirm these preliminary findings.  Furthermore, the reported decrements in satellite 
cell activity (as assessed by muscle [c-met]) may indicate that a greater impetus is needed 
to activate satellite cells and stimulate muscle hypertrophy.   Nonetheless, the current 
findings suggest that the examined cell cycle regulator mRNAs as well as IGF-1 variants 
are similarly expressed at baseline and following exercise between age groups raising the 




related differences in satellite cell physiology in response to exercise.    To this end, 
future research should determine how endogenous decrements in circulating factors (i.e., 
hormones, leukocytes, and growth factors), niche factors (i.e., intramuscular fibroblast 
and adipocyte signaling), and other intrinsic factors (i.e., the Notch signaling cascade as 
an example) contribute to decrements in satellite cell activity with aging.  These data will 
enable clinicians to develop more effective therapies at combating age-related muscle 
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Table 2. Primer sequences used to probe genes of interest expressed in skeletal muscle 
samples 





























5’- GGC TGG GAG ACT GAA GAC -3’ 
5’- GTA GAA GGG ACA AAC AAG GG -3’ 
 
5’- GGA GTG AGC AAT GGA GTG -3’ 
5’- GGA AGG AGA AGG AGA AGC -3’ 
 
5’- TTG GTT ACA GTA GCG TAG -3’ 
5’- TTA TAG TAG CGT ATC GTA GG -3’ 
 
5’- GAC ATG CCC AAG ACC CAG AAG GA -3’ 
5’- CGG TGG CAT GTC ACT CTT CAC TC -3’ 
5’- CGA AGT CTC AGA GAA GGA AAG G -3’ 
5’- ACA GGT AAC TCG TGC AGA GC -3’ 
 
5’-  CAA GAA TGA GGA AAT TCA GAG G -3’ 
5’-  CTT GCT CCT GGA AAG TTG G -3’ 
 
5’- CAC AAC GGA CGA CTT CTA TG -3’ 
5’- TGC TCT TCG GGT TTC AGG -3’ 
 
5’- CAG CAT GAC AGA TTT CTA CC -3’ 
5’- GGA ATC AGA GTC AAA CAC AC -3’ 
 
5’- CAG GAG AGC CAG GAT GTC-3’ 













Abbreviations – cdk: cyclin dependent kinase, IGF-1Ea: insulin-like growth factor-1Ea; 
MGF: mechano growth factor; MHCemb: embryonic myosin heavy chain; MyoD: 






Table 3. Normality distribution tests for all dependent variables 
Shapiro-Wilk statistic p-values for each dependent variable 
(H0: data is normally distributed) 
Dependent Variable T1 p-value T2 p-value T3 p-value T4 p-value 
Muscle [total RNA] 0.67 0.95 0.17 0.51 
Muscle [DNA] 0.22 0.36 0.61 0.17 
Muscle [total protein]* 0.029 0.014 0.19 0.34 
Muscle [myofibrillar  
protein]* 0.40 0.30 0.27 0.022 
MGF mRNA* < 0.001 0.36 0.07 0.007 
CDK2 mRNA* < 0.001 0.041 0.003 0.004 
CDK4 mRNA* 0.09 0.38 0.002 0.43 
CYCLIN D1 mRNA* < 0.001 0.38 0.003 0.008 
IGF-1EA mRNA* 0.035 0.059 0.85 0.025 
MGF:IGF-1EA mRNA* 0.022 0.95 0.72 0.23 
MHCEMB mRNA* 0.44 0.014 < 0.001 0.001 
MYOD mRNA* 0.036 0.008 0.12 < 0.001 
P21CIP1 mRNA 0.06 0.40 0.73 0.18 
P27KIP1 mRNA 1.00 0.69 0.52 0.54 
Muscle [PCNA]* 0.004 0.021 0.042 0.025 
Muscle [c-met]* 0.011 0.37 0.39 0.031 
Muscle [IGF-1]* < 0.001  < 0.001  < 0.001  < 0.001 
Symbols  – *: indicates that data at one or multiple time points from T1-T4 was not 








Figure 1. Summary of Mauro’s hypotheses on the origin of satellite cells (from reference 
[35]):  
A)  Mauro comments upon the possibility that a myonucleus of a damaged 
myofiber may dedifferentiate an pinch off to form a satellite cell which is then 
able to re-contribute itself to the damaged myofiber; a hypothesis which 
Mauro himself is uncharacteristic.   
B)  Mauro hypothesized that the satellite cells may arise from residual cells that 
did not fuse during embryonic and post-natal myogenesis; a hypothesis which 
was later confirmed using time-lapse microscopy [40].   
C)  Mauro also commented upon the possibility of wandering stem cells 
infiltrating muscle tissue to contribute to the satellite cell population; a 
hypothesis which may also hold true due to the presence of multipotent stem 
cells in the muscle bed [42]. 
 
Figure 2. The behavioral comparison of “conventional” satellite cells versus multipotent 
satellite stem cells.   
A) The depiction of two phenotypically distinct satellite cell populations as 
described by Zammit et al. [42] in which the majority group of resident 
satellite cells rapidly proliferates following an acute mitogenic (i.e., exercise) 
stimulus whereas the minority group of satellite stem cells undergoes 
prolonged proliferation periods.   
B) The depiction of these two cell lines proliferating following a series of 
mitogenic events followed by the eventual differentiation and fusion of a 
single myoblast to the pre-existing fiber.  Note that satellite stem cells (~10%; 
possibly mesenchymal and/or hematopoietic stem cells) are multipotent in that 
they can also differentiate into a non-myogenic cellular species under other 
circumstances (i.e., vascular cell species via vascular growth factor signaling). 
 
Figure 3. The manner in which myonuclear domains plausibly regulate satellite cell 
activity.  Mechanistically, this process may occur by virtue of the myonuclear domain 
expressing a negative growth factor (myostatin???) signal which quells satellite cell 
activation, proliferation, and differentiation.  The following steps describe how an early-
phase increase in hypertrophy expands the myonuclear domain which obviates the need 
for myonuclear addition:  
Step 1 (within 1-2 days ???): The splitting of myofibrils occurs due to 
intermittent, forceful eccentric contractions during resistance training [138].  
Further, the early expression of MGF and/or mechanoreceptor activation increases 
the synthesis of new myofibrillar proteins within the pre-existing domain.  At this 
point, the radial expansion of the fiber allows some of the split myofibrils as well 
as a group of satellite cells to fall outside of the myonuclear domain.  The lack of 
myostatin (???) signaling in concert with MGF signaling induces proliferation in 




Step 2: Delayed IGF-1Ea signaling induces one proliferating myoblast to 
differentiate.   
Step 3: The fusion of the newly differentiated myoblast allows for the 
transcription and synthesis of myofibrillar proteins following subsequent exercise 
stimuli. 
 
Figure 4. The postulated post-exercise molecular phenomena that occur in post-mitotic 
fibers versus satellite cells following an exercise stimulus: 
A) The transient post-exercise mRNA/protein expression and secretion of MGF 
from post-mitotic fibers acts to signal satellite cells in an IGF-1 receptor-
independent paracrine fashion which induces the expression of cyclins and 
leads to an increase in satellite cell proliferation [27, 76].   
B) The delayed mRNA/protein expression of IGF-IEa from post-mitotic fibers 
and satellite cells (F) acts to possibly increase the expression of MRFs, initiate 
differentiation, and stimulate protein synthesis in newly differentiated 
myoblasts [27].   
C) The mRNA/protein expression of cell cycle/differentiation-regulating genes 
likely does not occur in post-mitotic cells [99, 100].   
D) The mRNA/protein expression and increased activities of cdk-cyclin genes 
and concomitant depression in p27Kip1 occurs in satellite cells and acts to 
increase DNA replication and mitosis resulting in an increase in [DNA] (E) 
within 24 hours following exercise [27, 65].  The variable expression of 
MyoD during early post-exercise time points indicates that cells which 
subsequently differentiate may have elevated MyoD concentrations, whereas 
proliferating cells that do not differentiate may have depressed MyoD 
concentrations [68].  Finally, the increased expression of p21Cip1 within 
satellite cells may act to assist in the assembly of cdk-cyclin complexes [139], 
or may act to quell differentiation until the addition of myonuclei to pre-
existing fibers are needed.   
F) A delayed expression of myogenin, IGF-IEa, and possibly p27Kip1 within 
satellite cells acts to confer myoblast differentiation following proliferation 
events [20] assuming that myonuclear addition is needed. 
 
Figure 5.  Study Design.  All workouts (dark gray and black bars) consisted of a 5-minute 
warm-up on a cycle ergometer followed by 3 sets of 10 repetitions for the bilateral leg 
press, hack squat, and leg extension exercises (intensities denoted) with 2-3 minutes of 
rest between sets and exercises.  Note that FAMs 1 and 2 will serve to progressively ease 
all participants into the lower body workouts and that this strategy has been previously 
performed by Bamman and colleagues [18]. 
 
Figure 6.  RNA automated electrophoresis electropherogram.  Past data from our 
laboratory demonstrating that our isolation techniques yields high quality RNA as 
evidenced by the presence of 18S and 28S rRNA peaks and an RNA Quality Indicator 
(RQI) score of 7.0 [140] as well as the lack of high molecular weight peaks past the 28S 





Figure 7. Muscle [DNA] values expressed as means ± SE.  There were no between-group 
or within-group changes over the exercise intervention. 
 
Figure 8. Muscle [total protein] values expressed as means ± SE.  There were no 
between-group or within-group changes over the exercise intervention. 
 
Figure 9. Muscle [myofibrillar protein] values expressed as means ± SE.  There were no 
between-group or within-group changes over the exercise intervention. 
 
Figure 10. Muscle [total RNA] values expressed as means ± SE.  ∆1,2: Significant 
increase in muscle [total RNA] within the young (p = 0.021) and old (p = 0.010) groups 
from T3 to T4 denoted by the dashed and solid lines, respectively.  ∆3: Significant 
decrease in muscle [total RNA] within the old group (p = 0.021) groups from T3 to T4 
denoted by the solid line. 
 
Figure 11. MGF mRNA expression values expressed as means ± SE.  ∆1-3: Significant 
increase in muscle MGF mRNA expression within the old group from T2-4 compared to 
T1 (p < 0.05). 
 
Figure 12. CDK2 mRNA expression values expressed as means ± SE.  There were no 
between- or within-group differences (p > 0.05).  
 
Figure 13. CDK4 mRNA expression values expressed as means ± SE.  There were no 
between- or within-group differences (p > 0.05).  
 
Figure 14. CYCLIN D1 mRNA expression values expressed as means ± SE.  ‡1, 2: 
expression values were significantly greater in the older versus younger group at T1-2 (p 
< 0.05).  There were no within-group differences (p > 0.05).  
 
Figure 15. IGF-1EA mRNA expression values expressed as means ± SE.  There were no 
between- or within-group differences (p > 0.05).  
 
Figure 16. MGF:IGF-1EA mRNA expression values expressed as means ± SE.  These 
values discern the proportion of the IGF-1 gene that is being spliced into MGF.  ∆1-2: 
Significant increase in muscle MGF:IGF-1EA mRNA expression within the old group 
from T3-4 compared to T1 (p < 0.05). 
 
Figure 17. MHCEMB mRNA expression values expressed as means ± SE.  ∆: Significant 
increase in muscle MHCEMB mRNA expression within the young group from T4 
compared to T1 (p < 0.05). 
 
Figure 18. MYOD mRNA expression values expressed as means ± SE.  ∆: Significant 
increase in muscle MYOD mRNA expression within the young group from T2 compared 





Figure 19. P21CIP1 mRNA expression values expressed as means ± SE.  There were no 
between- or within-group differences (p < 0.05).   
 
Figure 20. P27KIP1 mRNA expression values expressed as means ± SE.  There were no 
between- or within-group differences (p > 0.05).  
 
Figure 21. Muscle [PCNA] values expressed in ADUs as mean ± SE.  There were no 
between- or within-group differences (p > 0.05).  The inset figure above provides 
representative Western blots from a young and old subject over the training intervention. 
 
Figure 22. Muscle [c-met] values expressed in ADUs as mean ± SE.  ∆1-2: Significant 
increase (at T1) and decrease (at T4), respectively, in muscle [c-met] values within the 
young group compared to T1 (p < 0.05).  The inset figure above provides representative 
slot blots from a young and old subject over the training intervention.  It should be noted 
that the secondary antibody solution was confirmed to yield no chemiluminescent signal 
and that the signal from the slot-blots were generated from primary antibody binding to 
the target antigen. 
 
Figure 23. Muscle [IGF-1] values expressed in ng/mg skeletal muscle as mean ± SE.  





      
  
 Consent Form 
University of Oklahoma Health Sciences Center (OUHSC) 
University of Oklahoma-Norman 
 
Impact of Age on Insulin and Androgen Receptor Expression and Binding Affinity 
after Sequential Sessions of Lower Body Resistance Exercise 
 
Sponsor: Department of Health and Exercise Science, University of Oklahoma 
 
Principal Investigator: Chad M. Kerksick, PhD 
University of Oklahoma 
405-325-9021 
 
This is a research study.  Research studies include only patients who choose to take part 
in them. Please take your time to make your decision. Discuss this with your family and 
friends. 
 
Why Have I Been Asked To Participate In This Study? 
You are being asked to take part in this study because you are a healthy 
man who is able to exercise. 
 
Why Is This Study Being Done? 
Aging in men is associated with decreases in androgens (male hormones).  
Testosterone is a type of androgen hormone. Decreased testosterone as a result of aging 
can lead to changes in muscle, including a loss of muscle and muscle strength. In this 
study, blood and muscle samples will be collected in order to compare amounts of 
testosterone and how receptive the muscles are to effects of androgens in younger and 
older men. The purpose of this study is to assess whether three sessions of lower 
extremity strength training changes the receptiveness to androgens in the muscle in 
elderly men compared to younger men. 
 
What is the Status of the Drugs (Devices or Procedures) involved in this study? 
No experimental drugs or foods will be used in this protocol.  Lidocaine is 
approved by the FDA as a local anesthetic. 
 
How Many People Will Take Part In The Study? 
About twenty men between the ages of 18-25 and 60-75 years of age will be 
divided into two groups by their age to take part in this study.  All of the participants will 
complete their testing in the research laboratories in the Huston Huffman Center on the 
University of Oklahoma-Norman campus.  
 




During this time you will complete one familiarization visit prior to completing 
five visits to the lab.  Each visit is outlined below: 
 
• Familiarization: Initial familiarization to the study protocol will occur by phone 
with one of the study investigators.  During this visit, the study investigator will 
ask you about your family and personal health history in addition to various 
lifestyle habits, which will include your current alcohol and illegal drug use. 
• Visit #1 –During this visit, your highest level of strength will be determined.  
Your strength will be determined using three separate weight lifting exercises that 
will focus on the muscles in your legs.  To complete this, low amounts of weight 
will first be used and the amount of weight will be slowly increased until the 
highest amount of weight you can lift is determined.  You will be allowed to rest 
for 3 minutes between each attempt at lifting the weight.  Trained investigators 
will be present to instruct you on how to safely and effectively complete the 
exercises. 
• Visit #2 - Two weeks after visit #1, all participants will return to the laboratory 
for approximately 60 minutes to complete visit #2. All participants will first 
complete a warm-up which will consist of walking for 10 minutes at a speed with 
which you are comfortable walking and lifting weights with amounts that will be 
half of what you completed at the first testing session.  For example, if your 
maximum amount was 100 pounds, you will warm-up with 50 pounds.  After 
warming up, you will then complete three sets of 8 to 10 repetitions (a repetition 
is lifting and lowering the weight once in a controlled manner) with all three 
exercises.  The amount of weight you will use will be equal to 80% of your 
maximum amount (Example: If your maximum amount was 100 pounds, you will 
use 80 pounds). You will rest for 3 minutes between each set of exercise. If the 
weight becomes too great, the amount of weight will be decreased so you can 
complete all of the repetitions.  Prior to beginning this exercise bout, you will 
have a small sample of muscle tissue removed from the outside portion of your 
thigh, halfway between your hip bone and your kneecap. The amount of muscle 
tissue will be equivalent to the size of a lead tip from a No. 2 pencil. During this 
procedure, your skin will be made numb using the same numbing agent that is 
used at the dentist. The needle used for this procedure is larger than a needle 
which is used for drawing blood.  A small incision, approximately one-quarter of 
an inch will be made to more easily insert the muscle collection needle.  As 
mentioned earlier, your skin will be made numb and as a result you will feel very 
little pain and likely significant pressure while the procedure is being completed.  
This entire process should take approximately one to two minutes.  The muscle 
collection will be completed by Chad Kerksick, PhD, who is a professor of 
exercise physiology at the University of Oklahoma. Dr. Kerksick will be assisted 
by trained graduate students to assist him with this procedure.  Prior to beginning 
the exercise session, immediately after the exercise session and 30 minutes after 
completing the exercise session, you will have approximately 15 milliliters (one 
tablespoon) of blood drawn from a vein located in the area in front of your elbow. 
The needle and supplies used are similar to what is used by your physician’s 




graduate students trained in phlebotomy.  It is important for you to follow all 
instructions provided to you by Dr. Kerksick and his staff to minimize any 
bruising and/or discomfort you may feel from the muscle collection and blood 
draw. To ensure your safety and provide medical care, Steven Blevins, MD and 
Ryan Brown, MD will be available to provide medical consult to Dr. Kerksick 
and his staff if you experience any unexpected problem. This is important for you 
to understand since Dr. Brown and Dr. Blevins will not be available on-site for 
emergencies but will be available for medical consultation for cases of infection, 
hematomas, etc. 
• Visit #3 – Approximately 48 hours after visit #2, participants will return to the 
laboratory for approximately 60 minutes to complete their second exercise 
session, which will be identical to visit #2. Immediately before this exercise 
session a blood and muscle sample will be collected.  Two additional blood 
samples will then be collected immediately after and 30 minutes after completing 
this exercise session.  All blood and muscle samples collected during this visit 
will follow the procedures outlined previously in the Visit #2 section. 
• Visit #4 – Approximately 48 hours after visit #3, participants will return to the 
laboratory for approximately 60 minutes to complete their third and final exercise 
session, which will be identical to the two previous exercise sessions.  
Immediately before this exercise session a blood and muscle sample will be 
collected.  Two additional blood samples will then be collected immediately after 
and 30 minutes after completing this exercise session.  All blood and muscle 
samples collected during this visit will follow the procedures outlined previously 
in the Visit #2 section. 
• Visit #5 – Approximately 24 hours after visit #4, participants will return for their 
final muscle collection following the previously outlined procedures. 
 
How Long Will I Be In The Study? 
This study should last for 21 days.  There may be anticipated circumstances under 
which your participation may be terminated by the investigator without regard to your 
consent, which include: 
• He feels that it is in your medical best interest. 
• Your condition worsens. 
• New information becomes available. 
• The study is stopped by the sponsor. 
You can stop participating in this study at any time. 
 
What Are The Risks of The Study?  
While on the study, you are at risk for these side effects. You should discuss these 
with the researcher and/or your regular doctor prior to providing your consent to 
participate. 
 





- Feeling faint, lightheaded, or nauseated before, during and immediately after 
the blood and muscle collection.  This is a common response and subsides in 
most individuals upon completion. 
- Pain, bruising, feeling faint and arm soreness from having your blood drawn 
during the 48 to 72 hours after completion. 
- Pain, bruising, feeling faint and muscle soreness from having the muscle 
collection performed during the 48 to 72 hours after completion. 
- Muscle soreness or stiffness from completing maximal strength tests and the 
exercise sessions during the 48 to 72 hours after completion. 
- Shortness of breath during the exercise testing and exercise sessions. 
 
 
Less Likely To Occur but Serious 
- An allergic reaction to Lidocaine. 
- Chest pain, heart attack and abnormal heart rhythm during the exercise testing 
and exercise sessions. 
 
Less Likely To Occur 
- Slight risk of infection from having your blood drawn and the muscle 
collection during the 48 to 72 hours after completion 
 
Are There Benefits to Taking Part in The Study?  
There is no direct benefit to you to participate in this study, but the information 
from this study may increase knowledge about the effects of aging on male hormones, 
muscle strength, and exercise. 
 
What Other Options Are There?  
Your alternative is to not participate. 
 
What about Confidentiality? 
Efforts will be made to keep your personal information confidential. You will not 
be identifiable by name or description in any reports or publications about this study. We 
cannot guarantee absolute confidentiality. Your personal information may be disclosed if 
required by law.  You will be asked to sign a separate authorization form for use or 
sharing of your protected health information. 
There are organizations that may inspect and/or copy your research records for 
quality assurance and data analysis. These organizations include faculty members and 
graduate students appointed to this protocol from the Health and Exercise Science 
department at the University of Oklahoma and the OUHSC Institutional Review Board.  
 
What Are the Costs? 
There is no cost to you for participating in this study. 
 
 




All individuals will be compensated for their time commitment associated with 
the study.  Participants will be paid $50 for each visit, and a total of $200.  
 
What if I am Injured or Become Ill While Participating in this Study? 
In the case of injury or illness resulting from this study, emergency medical 
treatment will be available.  If injury occurs as a result of participation, you should 
consult with your personal physician to obtain treatment.  No funds, however, have been 
set aside by The University of Oklahoma Health Sciences Center or University of 
Oklahoma to compensate you or pay for the costs associated with treatment in the event 
of injury.  
 
What Are My Rights As a Participant? 
Taking part in this study is voluntary. You may choose not to take part or may 
leave the study at any time. If you agree to take part and then decide against it, you can 
withdraw for any reason, so please be sure to discuss leaving the study with the principal 
investigator or your regular physician. Refusal to participate will not result in any penalty 
or loss of benefits that you are otherwise entitled. 
We will tell you about any significant new findings developed during the course 
of the research that may affect your health, welfare or willingness to stay in this study. 
You have the right to request the medical information that has been collected 
about you as a part of this research study.  At this point, you will not have access to the 
biomedical related information that will be collected from you during this study and you 
consent to this restriction. 
For questions about your rights as a research participant, contact the OUHSC 
Director, Office of Human Research Participant Protection at 405-271-2045. 
 
Whom Do I Call If I have Questions or Problems? 
If you have questions, concerns, or complaints about the study or have a research-
related injury, contact Chad Kerksick, PhD at 405-325-9021 (office) or 405-248-8730 
(cell). 
If you cannot reach the Investigator or wish to speak to someone other than the 
investigator, contact the OUHSC Director, Office of Human Research Participant 
Protection at 405-271-2045. 
For questions about your rights as a research participant, contact the OUHSC 




By signing this form, you are agreeing to participate in this research study under the 
conditions described. You have not given up any of your legal rights or released any 
individual or entity from liability for negligence. You have been given an opportunity to 
ask questions. You will be given a copy of this consent document. 
 





Research Subject: ______________________________________       
Date:______________________ 
 
Subject's Printed Name: __________________________________ 
 








University of Oklahoma 
 
Impact of Age on Androgen Receptor Expression and Binding Affinity after Sequential 
Bouts of Lower Body Resistance Exercise  
 
General Health and History Form 
Side A 
Demographics: 
Name: ______________________________________    Subject number: _________ 
Date: ________________ Age: ___________ Birth Date: ______________ 
Daytime phone: _______________ Evening contact number: ___________________  
 
Family History: 
Has anyone in your immediate family had any of the following: Please circle yes or no 
 
Heart disease   Yes No  Diabetes  Yes No 
High blood pressure  Yes No  Cancer   Yes No 
Stroke    Yes No  Tuberculosis  Yes No 
Sudden Death (before 50) Yes No  Asthma  Yes No 
Epilepsy   Yes No  Gout   Yes No 
Migraine Headaches  Yes No  Marfan’s Syndrome Yes No 
Eating Disorder  Yes No  Sickle Cell  Yes No 
 
Personal History: 
1. Have you ever been hospitalized?      Yes No 
Have you ever had surgery?       Yes No 
Are you presently under a doctor’s care?     Yes No 
Please explain and give dates for all “Yes” answers: ____________________________ 
 
2. Please list any medications you are currently taking and for what conditions: ______ 
 
3. Please list any known allergies: __________________________________________ 
 
4. Have you ever had a head injury / concussion?    Yes No 
Have you ever been knocked out or unconscious?    Yes No 
Have you ever had a seizure, “fit”, or epilepsy?    Yes No 
Have you ever had a stinger, burner, or pinched nerve?   Yes No 
Do you have recurring headaches or migraines?    Yes No 
Please explain and give dates of “yes” answers: ________________________ 
5. Have you ever had the chicken pox?     Yes No 
 If Yes, at what age? _________ 
 





7. Do you have a history of asthma?      Yes No 
 
8. Are you missing an eye, kidney, lung, or testicle?    Yes No 
 
9. Do you have any problems with your eyes or vision?   Yes No 
 
10. Have you ever had any other medical problems     Yes No 
(mononucleosis, diabetes, anemia)? 
 
11. Have you ever taken any supplements for improved performance? Yes No 
 
12. Are you presently taking any supplements for diet or performance Yes No 
(creatine, protein, etc.)? 
 
University of Oklahoma 
 
Impact of Age on Androgen Receptor Expression and Binding Affinity after Sequential 
Bouts of Lower Body Resistance Exercise 
 
General Health and History Form 
Side B 
13. What is the lowest weight you have been at in the last year _______? 
Highest _______, what is your ideal weight _________? 
 
14. Do you have any trouble breathing or do you cough during or after practice? 
 Yes No 
 
15. Have you ever had heat cramps, heat illness, or muscle cramps? Yes No 
 
16. Do you have any skin problems (itching, rashes, or acne)?  Yes No 
 
Explain all “Yes” answers for question 5 -16: __________________________________ 
 
17. Have you ever passed out during or after exercise?   Yes No 
Have you ever been dizzy during or after exercise?    Yes No 
Have you ever had chest pain during or after exercise?   Yes No 
Have you ever had high blood pressure?     Yes No 
Have you ever been told you have a heart murmur?    Yes No 
Have you ever had racing of your heart or a skipped heartbeat?  Yes No 
Have you ever had an EKG or echocardiogram?    Yes No 
 
Explain all “Yes” answers for question 17: ____________________________________ 
 
18. Have you ever sprained / strained, dislocated, fractured, or had repeated 





Head / Neck   Yes No  ___________________________ 
Shoulder   Yes No  ___________________________ 
Elbow & Arm   Yes No  ___________________________ 
Wrist, hand & Fingers Yes No  ___________________________ 
Back    Yes No  ___________________________ 
Hip / Thigh   Yes No  ___________________________ 
Knee    Yes No  ___________________________ 
Shin / Calf   Yes No  ___________________________ 
Ankle, foot, toes  Yes No  ___________________________ 
 
Please Sign: 
I hereby state that, to the best of my knowledge, my answers to the above 
questions are correct. 
 
 







Department of Health and Exercise Science - University of Oklahoma-Norman 
Campus 
 
Effects of repeated bouts of weight-training on androgen receptor expression in skeletal 
muscle of young versus old participants 
 
To the Attending Physician of: _____________________________________                               
 
This individual has indicated that he wishes to participate in a research study 
investigating the effects of resistance training of intramuscular markers of muscle growth 
in younger and older men.  The outcomes of this study will help researchers further 
delineate how exercise can combat muscle aging.  This project has been approved by the 
Institutional Review Board at the University of Oklahoma. 
 
Description of the Study 
This study will consist of 7 visits to the laboratory.  During this first visit, all participants 
will have their maximal strength determined in their lower extremity muscles (see 
exercises below in the “Resistance training” sub-section).  Before this strength 
determination blood pressure will be obtained a small sample of muscle tissue from the 
thigh region will be collected.  In short, this muscle collection involves the use of local 
anesthesia (2% Lidocaine) and a 5-mm Bergstrom biopsy needle.  Our lab has previously 
performed these specimen collection procedures in hundreds of participants and no one to 
date has reported any deleterious side-effects. 
  
Resistance training 
The strength assessment and workouts consist of lower body resistance exercises using a 
modified squat (minimally stressing the lower back), leg press, and a leg extension 
machine.   
 
Visits 2 and 3 
Participants will perform 2 sets of 10 repetitions of each of the 3 exercises including a 
modified squat (minimally stressing the lower back), leg press, and leg extension 
exercise.  These visits are considered to be practice exercise bouts to familiarize the 
participant with resistance training. 
 
Visits 4, 5, 6 and 7 
Participants will report to the lab on Mon (visit 4), Wed (visit 5), Fri (visit 6), and Sat 
(visit 7).  During visits 4, 5, and 6 the participant will perform 3 sets of 10 repetitions of 
each of the 3 exercises including a modified squat (minimally stressing the lower back), 
leg press, and leg extension exercise.  Muscle will be collected prior to exercise (on visits 
5, 6) and blood only will be collected after exercise (on visits 4, 5, 6).  Blood and muscle 





Please advise the investigators regarding any physical limitations and/or 
contraindications that this patient might have from engaging in this exercise study.           
 
Pertaining to the above mentioned patient, I advise the following: 
 
 To my knowledge, there is no reason why this patient should not be allowed to 
participate in this study. 
 I recommend that this patient be allowed to participate in the study with the 
following restrictions:_______________________________________________ 
 I recommend that this patient should not be allowed to participate in the study for 
the following reasons:_______________________________________________ 
 
Physician’s Name _________________________________Date____________   
 
If you have any questions about this form, please contact: Chad Kerksick, Ph.D., 
Assistant Professor, Director, Applied Biochemistry and Molecular Physiology 
Laboratory at 405-325-9021. 
